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Abstract 
 
Connexin proteins are the principle structural components of gap junction 
channels that connect the cytoplasm of two cells and maintain direct intercellular 
communication through the exchange of ions, small molecules and cellular metabolites. 
Colocalization and tissue-specific expression of diverse connexin molecules are 
reported to occur in a variety of organs. Impairment of gap junctional intercellular 
communication, caused by mutations, gain of function or loss of function of connexins, 
is involved in a number of diseases including the development of cancer. Here the 
functions of a gap junction protein, connexin46 (Cx46), have been investigated in two 
hypoxic tissues, lens and breast tumor. We show that human breast cancer cells, MCF-
7 and breast tumor tissues express connexin46 (Cx46) and it plays a critical role in 
protecting cells against hypoxia-induced death. Interestingly, I find that Cx46 is 
upregulated in MCF-7 breast cancer cells and human breast cancer tumors. 
Downregulation of Cx46 by siRNA promotes cell death of human lens epithelial cells 
(HLEC) and MCF-7 cells under hypoxic conditions. Furthermore, direct injection of anti-
Cx46 siRNA into xenograft tumors prevents tumor growth in nude mice. Our result 
suggests that both normal hypoxic tissue (lens) and adaptive hypoxic tissue (breast 
tumor) utilize the same protein, Cx46, as a protective strategy against hypoxia. 
 
In the last part of the dissertation, we show that overexpression of Cx46 induces 
the degradation of another connexin, connexin43, in rabbit lens epithelial NN1003A 
cells. Overexpression of Cx46 increases ubiquitination of Cx43. Moreover, the Cx46-
induced Cx43 degradation is counteracted by inhibitors of proteasome. Taken together, 
these data indicate that the degradation of Cx43, upon Cx46 overexpression, is 
mediated by the ubiquitin-proteasome pathway. I also provide evidence that that C-
terminal tail of Cx46 is essential to induce degradation of Cx43. Therefore, our study 
shows that Cx46 has a novel function in the regulation of Cx43 turnover in addition to its 
conventional role as a gap junction protein. This may contribute to protection from 
hypoxia in both the lens and tumors. 
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Abstract 
Connexin proteins are the principle structural components of gap junction 
channels that connect the cytoplasm of two cells and maintain direct intercellular 
communication through the exchange of ions, small molecules and cellular metabolites. 
Colocalization and tissue-specific expression of diverse connexin molecules are 
reported to occur in a variety of organs. Impairment of gap junctional intercellular 
communication, caused by mutations, gain of function or loss of function of connexins, 
is involved in a number of diseases including the development of cancer. Here the 
functions of a gap junction protein, connexin46 (Cx46), have been investigated in two 
hypoxic tissues, lens and breast tumor. I show that human breast cancer cells, MCF-7 
and breast tumor tissues express connexin46 (Cx46) and it plays a critical role in 
protecting cells against hypoxia-induced death. Interestingly, I find that Cx46 is 
upregulated in MCF-7 breast cancer cells and human breast cancer tumors. 
Downregulation of Cx46 by siRNA promotes cell death of human lens epithelial cells 
(HLEC) and MCF-7 cells under hypoxic conditions. Furthermore, direct injection of anti-
Cx46 siRNA into xenograft tumors prevents tumor growth in nude mice. Our result 
suggests that both normal hypoxic tissue (lens) and adaptive hypoxic tissue (breast 
tumor) utilize the same protein, Cx46, as a protective strategy against hypoxia. 
 
In the last part of the dissertation, I show that overexpression of Cx46 induces 
the degradation of another connexin, connexin43, in rabbit lens epithelial NN1003A 
cells. Overexpression of Cx46 increases ubiquitination of Cx43. Moreover, the Cx46-
induced Cx43 degradation is counteracted by inhibitors of proteasome. Taken together, 
these data indicate that the degradation of Cx43, upon Cx46 overexpression, is 
mediated by the ubiquitin-proteasome pathway. I also provide evidence that that C-
terminal tail of Cx46 is essential to induce degradation of Cx43. Therefore, our study 
shows that Cx46 has a novel function in the regulation of Cx43 turnover in addition to its 
conventional role as a gap junction protein. This may contribute to protection from 
hypoxia in both the lens and tumors. 
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CHAPTER 1 - Introduction and Literature Review 
 1.1. Introduction 
The animal body is a dynamic organism comprised of cells, tissues and organs 
that act in a highly coordinated fashion to maintain cellular homeostasis. In a 
multicellular organism, homeostasis is regulated by extracellular and intracellular 
communication processes involving hormones, growth factors, cytokines, and direct 
cell-to-cell contacts or cell junctions (Trosko and Ruch 1998). Cell junctions can be 
those that link cells together or those that link cells to the extracellular matrix. Cell 
junctions, connecting two adjacent cells, are tight junctions, adherent junctions and gap 
junctions. While tight junction connects cells at the apical surface, gap junctions are 
present at the basolateral surface (Shin, Fogg et al. 2006). Gap junctions can pass 
helpful or harmful signals to the neighboring cells and gap junction mediated 
communications play critical roles in normal physiological processes such as cell 
growth, differentiation and proliferation and in diseased processes including 
carcinogenesis, lens cataract formation, heart arrhythmia and many more (Loewenstein 
1979; Trosko and Ruch 1998; Yamasaki, Krutovskikh et al. 1999; Laird 2006). In the 
dissertation, I document my research that explores the novel functions of a gap junction 
protein, connexin 46, in two hypoxic tissues, vertebrate lens and breast tumor. Since 
connexin46 belongs to the family of gap junction connexin proteins, I will review the 
connexins including their expression, structure, synthesis and degradation, in Chapter 1 
of the dissertation, in detail. I will also review the connexins, including connexin46, 
which are expressed in lens and breast tumor. Hypoxic properties of lens and breast 
tumor will be reviewed in this chapter. In Chapter 2, a role of connexin46 protecting lens 
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and breast tumor from hypoxia is presented and in Chapter 3, the function of 
connexin46 in the degradation of another gap junction connexin, connexin 43, is 
presented. 
 1.2. Gap Junctions  
 
               Gap junctions are intercellular membrane channels that maintain direct 
intercellular communication through the exchange of ions, small molecules and cellular 
metabolites between neighboring cells (Goodenough, Goliger et al. 1996; Harris 2001). 
Gap junction channels are formed at the basolateral surfaces of two cells and connect 
directly to their cytoplasms. The cell-to-cell communication through gap junctions is 
known as gap junctional intercellular communication (GJIC), proper functioning of which 
is very important to maintain tissue homeostasis. For example, vertebrate lens is an 
avascular tissue and therefore GJIC is the major process, along with diffusion, by which 
lens epithelial and fiber cells maintain intercellular homeostasis (Mathias, White et al. 
2010). 
 1.2.1. Gap Junctions: Structure of Connexin 
 
               One gap junction channel is composed of two hemichannels or a connexon 
(Goodenough 1976; Kumar and Gilula 1992). Each connexon, in turn, is formed through 
the hexameric oligomerization of proteins called connexins (Figure 1.1). Connexins are 
the multigene family of transmembrane proteins and they are the structural unit of gap 
junctions. So far, 21 connexin isoforms have been identified in humans (Sohl and 
Willecke 2004). Each of these connexin isoforms constitutes four hydrophobic 
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transmembrane helices, two extracellular loops (EL-1 and EL-2), a cytoplasmic loop 
(CL) and a carboxyl terminal (CT) and a amino terminal (AT) end, both termini are 
located at the cytoplasmic side (Milks, Kumar et al. 1988; Laird and Revel 1990; Zhang 
and Nicholson 1994; Sosinsky and Nicholson 2005) (Figure 1.1). All of the connexin 
isoforms show highly conserved sequence similarities within the four transmembrane 
domains, two extracellular loops and amino- terminal end (AT). Therefore, a highest 
degree of sequence diversity is seen mainly in the sequence and length of C-terminal 
ends (CT) and cytoplasmic loops (CL). The extracellular EL-1 and EL-2 are the most 
conserved residues and they are required for proper docking interaction of the 
hemichannels from two adjacent cells for the channel (gap junction) to form (Zhang and 
Nicholson 1994).  
               Connexons (hemichannels), from adjacent cells, can interact with each other 
via several ways (Sosinsky 1995; Jiang and Goodenough 1996; Desplantez, Halliday et 
al. 2004). If the hemichannel is composed of a single connexin isoform it is called 
homomeric. Heteromeric hemichannles are formed through the association of at least 
two different connexin isoforms. Homotypic channels are formed by the interaction of 
two identical homomeric hemichannels; in turn, when two different homomeric 
hemichannels interact to form a gap junction channel, it is known as a heterotypic 
channel. 
       Gap junction channels are aqueous channels that are permeable to several 
small ions including Ca2+, small metabolites such as ATP, ADP, IP3, sugars and small 
proteins with molecular weight less than 1KDa (Bennett and Verselis 1992; Wang, Lee 
et al. 2001; Bukauskas and Verselis 2004). The permeability properties shown by all 
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connexin channels differ and depend on the connexin isoforms that are expressed in 
the cell (Elfgang, Eckert et al. 1995; Goldberg, Valiunas et al. 2004; Kanaporis, Mese et 
al. 2008). The permeability of channels also alters in response to ions, voltage, pH, 
phosphorylation and other post-translational modifications (Mathias, Rae et al. 1997; 
Eckert 2002). For example, phosphorylation of connexin43 by the protein kinase C 
enzyme leads to channel closure and a decrease in GJIC in lens epithelial cells (Saleh 
and Takemoto 2000; Nguyen, Boyle et al. 2003). 
 
Figure 1.1 Structural organization of connexin and gap junction.  
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Schematic diagram of connexin43 (Cx43) and connexin 45 (Cx45) protein (top). Each 
connexin polypeptide spans the membrane four time with amino terminal (AT) end, 
carboxyl terminal (CT) end and carboxyl loop (CL) in the cytoplasm. Six connexin 
proteins oligomerize to form one connexon or hemichannel. Connexons from two 
apposing cells interact and form one gap junction channel (middle). Depending on the 
stoichiometry of the connexin subunits, gap junctions can be homotypic homomeric 
(identical connexin isoform sububit), heterotypic homomeric (each connexon has 
identical connexin isoforms that are different in two connexons) or heteromeric 
heterotypic (mixed connexin isoforms) (bottom). [Figure reprinted from Laird 2006 with 
kind permission from Biochemical  Journal] 
 1.2.2. Nomenclature of connexin 
 
       Connexins are named according to their molecular weight (MW). They are 
abbreviated as “Cx” followed by suffix that indicates the approximate molecular weight 
of the protein in kilo Daltons (kDa). For example, the protein Cx43 is a connexin protein 
that has the molecular weight of 43 kDa. Similarly, Cx46 is connexin protein with 
predicted molecular weight of 46 kDa. 
      Another nomenclature, used to identify the connexins, is developed on the 
based on the overall sequence similarities and length of cytoplasmic loops of connexins. 
This nomenclature separates connexins in two subgroups: α and β. The α-group 
includes Cx33, Cx37, Cx38, Cx40, Cx43, Cx45, Cx46, Cx50, and Cx56; while Cx26, 
Cx30, Cx30.3, Cx31.1, and Cx32 fall in to β-subgroup. This nomenclature is currently 
used for the official identification of different connexin genes in vertebrates. For 
instance, the official nomenclature of Cx43 gene in mouse is Gja1 and that in human 
GJa1. Where the word “Gap junction” is abbreviated as “Gj” for mouse or “GJ” for 
human, “a” stands for α- subgroup connexin and “a1” is given to the name since Cx43 
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was the first identified connexin gene of the α-group in mammals. Similarly, Cx32 gene 
is named as Gjb1 as it is the first identified connexin gene in the β-subgroup in mouse. 
     So far, 21 connexin genes in the human genome and 20 connexin genes in 
the mouse genome have been identified (Table 1.1). Connexin 33 gene is present only 
in mouse whereas Cx25 and Cx59  appear only in the human genome (Laird 2006). 
 
Table 1.1 Mouse and homologous human connexin family members  
(Reprinted from Laird, 2006 with permission from Biochemical Journal) 
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 1.2.3. Tissue specific expression of connexins 
 
               Connexins are expressed in almost all tissues (Table 1.2) with the exception of 
red blood cells, some neurons and spermatozoa (Laird 2006). In vertebrates, many 
tissues express two or more connexins. For example, vertebrate heart expresses Cx40, 
Cx43 and Cx45 (Beyer, Davis et al. 1995; Gros and Jongsma 1996; Moreno 2004) and 
normal breast tissue expresses Cx26, Cx32 and Cx43. When multiple connexin 
isoforms are expressed in one tissue type they can compensate for each other’s 
functions particularly when one connexin is mutated. For example, Cx57-null mice 
shows no apparent anatomical defects though Cx57 is only expressed in horizontal 
cells, indicating the existence of compensation of gap junction function by another 
connexin when Cx57 is absent (Hombach, Janssen-Bienhold et al. 2004). However, in 
some other cases, the presence of two or more connexins cannot compensate for the 
function of the connexin that is defective (White 2003). This has been shown in the skin 
where a subset of loss-of-function Cx26 mutations cause skin disease though the 
epidermis expresses many connexin isoforms, indicating a lack of compensatory 
mechanism by other connexins (Richard, Rouan et al. 2002). 
 
               Some connexins are very specific and some connexins are very abundant in 
terms of their tissue specific expression. For example Cx43 is one of the most abundant 
connexins in the body as more than 35 tissues have been reported to express this 
protein and, over the years, it is the connexin protein that has been studied most 
extensively among all isoforms. 
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Table 1.2 The expression pattern of connexin family members in tissues and 
corresponding cell types  
(Reproduced from Laird 2006 with permission from Biochemical Journal) 
 
 
 1.2.4. Connexin mutations and diseases 
 
                      Gap junction channels play major roles in the processes of cell growth, 
proliferation and development. Therefore several reports have been made on the 
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appearance of inherited diseases such as deafness, cataractogenesis and epidermal 
diseases associated with germline mutations of different connexin proteins (Liu, Walsh 
et al. 1997; Paznekas, Boyadjiev et al. 2003; Gerido and White 2004; van Steensel 
2004) (Table 1.3). The first disease that was discovered to be associated with connexin 
abnormalities was chromosome-X-linked Charcot-Marie-Tooth disease (peripheral axon 
demyelination and limb weakness) caused by over 270 possible mutations in the Cx32 
gene (Bergoffen, Scherer et al. 1993) that resulted in the inhibition of protein transport 
to the cell surface and inhibition of gap junction channel formation (Krutovskikh and 
Yamasaki 2000; Zhou and Griffin 2003). 
             Mutations can happen at genes leading to impaired transcription or, at a 
protein coding region, interfering with the normal translation process, resulting in loss of 
a protein expression or appearance of an abnormal protein with defective function. A 
nonsense mutation in the protein coding region of the Cx26 gene results in impaired 
translation and formation of a mutant protein that causes deafness (Carrasquillo, 
Zlotogora et al. 1997). Alterations can also happen at different steps of the connexin life 
cycle, including synthesis at the endoplasmic reticulum (ER), assembly and 
transportation via the trans-Golgi pathway, disrupting proper channel formation and 
function. For example, mutation D66H of Cx26 leads to mutilating keratoderma with 
sensorineural deafness due to the inability of the mutant protein to reach the cell 
surface for the proper gap junction channel to form (Maestrini, Korge et al. 1999; 
Bakirtzis, Choudhry et al. 2003). Mutations can also affect the compatibilities of 
oligomerization between two different connexin proteins. Wild type Cx43 and Cx26 do 
10 
 
not interact to form hemichannels. However, several Cx26 mutants, that cause skin 
diseases, can interact and inhibit the function of Cx43 (Rouan, White et al. 2001).  
Disease 
 
Connexins 
 
Neuropathy: Charcot-Marie-Tooth 
disease, X-linked type 1 (CMTX1) 
 
Cx32 
 
Deafness (nonsyndromic) 
 
 
Cx26, Cx31,Cx30,Cx43,Cx26 
 
Deafness (syndromic): Dominant deaf-
mutism and palmoplantar keratoderma 
 
Deafness, peripheral neuropathy 
 
Cx26 
 
                                 Cx31 
 
Skin Disease: Erythrokeratodermia 
variabilis 
 
 
Cx31, Cx30.3 
 
Skin Disease: Autosomal dominant 
hidrotic ectodermal dysplasia 
 
Cx30 
 
Oculodentodigital dysplasia 
 
 
Cx43 
 
Autosomal dominant zonular pulverulent 
catatact-3 
 
Cx46 
 
Table 1.3 Hereditary diseases linked with germline mutations in connexin.  
[Reprinted from Beyer 2009 with kind permission from Springer eBook] 
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1.2.5. Connexins and cancer 
 
               Cancer was the first disease that was identified to be associated with defective 
intercellular gap junction communication (GJIC). For more than 40 years, the loss of 
gap junction communication has been shown to be an important step in the 
development of carcinoma. Several reports have supported that the gap junction 
connexins function to control cell proliferation and differentiation, however, the 
molecular mechanisms of which are largely unexplained. Therefore, how connexins are 
involved in the carcinogenesis process is yet to be known in detail and is often 
controversial. One important observation, that is well-established, is that tumor 
progression is generally associated with the loss of gap junction contacts at cell 
surfaces. The decreased communication of tumor cells with neighboring normal cells 
due to the defective intercellular gap junctions has been shown to be beneficial for 
tumor progression and therefore connexins are deemed tumor suppressors. 
 
               The function of connexins in cell cycle progression is not clear. The current 
hypothesis proposes that connexins are “gatekeepers” of cell cycle progression that 
allows the passage of different regulatory molecules (Vinken, Vanhaecke et al. 2006). 
Therefore, the downregulation of connexin is not the consequence of loss of growth 
control during carcinogenesis, rather, it contributes to the loss of growth control. Studies 
have shown that GJIC increases during G1 phase and decreases during S phase in a 
model of rat liver regeneration. In another rat liver model it has been found that 
phosphorylation of Cx43 causes disruption of GJIC and it occurs during G0 to S phase 
transition (Lampe and Lau 2004). In addition, it has also been found that Cdc25A 
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phosphorylation can induce Cx43 phosphorylation resulting in loss of GJIC during the 
G1/S transition (Melchheier, von Montfort et al. 2005). 
 
The tumor suppressive mechanism of connexins is yet to be identified; probably 
it is mediated through a variety of pathways. One of the pathways by which connexins 
act as tumor suppressors is by negatively affecting growth factors. For example, Cx32 
inactivates growth factor Her-2 in metastatic renal carcinoma cell and therefore has a 
negative growth effect (Fujimoto, Satoh et al. 2004). Cx32 also inactivates SrC signaling 
pathway in the above cell line and this is associated with a reduced malignant 
phenotype (Fujimoto, Satoh et al. 2004; Fujimoto, Sato et al. 2005). The inactivation of 
Src pathways by Cx32 also contributes to the reduced production of vascular 
endothelial growth factor (VEGF). Another connexin, Cx43, has also been shown to 
regulate the growth of glioma cells by suppressing the expression of extracellular 
growth factor MFG-E8 (Goldberg, Bechberger et al. 2000). Cx43 also inhibits cell 
proliferation of osteosarcoma cells by negatively regulating S-Phase Kinase-associated 
Protein (Skp 2), a key cell cycle regulator (Zhang, Kaneda et al. 2003). 
                
The loss of intercellular gap junctional communication (GJIC) in tumor cells is believed 
to favor tumor progression. Aberrant localization of connexins, mainly lack of plasma 
membrane localization, has been observed in many tumor cell lines (Krutovskikh, 
Mazzoleni et al. 1994; de Feijter, Matesic et al. 1996; Kanczuga-Koda, Sulkowski et al. 
2005). In several colorectal cancer specimens, Cx26 was found to be predominantly 
present in the cytoplasm. Similarly, the expression of Cx26 is only seen in the 
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cytoplasm of breast tumor tissues (Kanczuga-Koda, Sulkowski et al. 2005). The 
cytoplasmic localization of connexin could be due to the impaired localization via a 
trans-Golgi network pathway to the cell surface or due to post transcriptional or post 
translational defects of those proteins in neoplastic cells. The cytoplasmic localization of 
connexin may also function to promote tumorigenesis by pathways independent of 
GJIC. Qin et al. (2002) found that restoration of Cx43 in human breast cancer cells 
suppressed tumor growth via mechanisms that were distinct and independent of GJIC 
(Qin, Shao et al. 2002). Forced expression of Cx43 inhibits proliferation of 
osteosarcoma cells without forming gap junction channels (Zhang, Kaneda et al. 2003). 
 
               Several reports have been made suggesting that connexins can directly affect 
the gene expression of different proteins involved in the process of cell growth and 
proliferation. Cx43 expression increases the expression of cyr61, a gene that encodes 
for a cysteine-rich heparin-binding protein involved in several cellular pathways (O'Brien 
and Lau 1992). In HEK293 cells, co-expression of Cx43 increases the expression of 
cyclin-dependent kinase inhibitor p21 which is a key regulator of the cell cycle at the G1 
phase (Kamei, Toyofuku et al. 2003). All these results point out the definite role of gap 
junctions in carcinogenesis but the exact mechanism of action is largely unknown. 
 
 1.3. Connexin turnover 
 
               Connexins have a very short half-life of 1.5 – 4 hr, depending on the cell type. 
The short half-lives of connexins have been well studied mainly in cell culture and in 
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tissue environments (Table 1.4) (Fallon and Goodenough 1981; Laird, Puranam et al. 
1991; Beardslee, Laing et al. 1998; Hertlein, Butterweck et al. 1998; Diestel, Eckert et 
al. 2004; Herve, Derangeon et al. 2007). This short half-life of a connexin is very 
unusual for an integral membrane protein whose half-life is expected to be long (>20 
hr)(Lukacs, Chang et al. 1993; Huh and Wenthold 1999; Kleyman, Zuckerman et al. 
2001). The reason for the rapid turnover rate of connexins is not well documented; 
however, it is assumed that connexins are continuously degraded and synthesized to 
increase or decrease the GJIC as per a cell’s physiological requirement. For instance, in 
the myometrium tissue of uterus, it has been found that steroid hormones increase total 
gap junctions to more than 5-fold just before the labour onset; however, the gap 
junctions declined significantly after the labour, indicating a requirement or lack of 
requirement of GJIC before and after the process, respectively (Risek, Guthrie et al. 
1990; Hendrix, Mao et al. 1992; Risek, Klier et al. 1995; Risek and Gilula 1996). 
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Connexin Half life (h) 
 
Cell or tissue 
Cx26 1.5-2 Cultured mouse hepatocytes (Fallon and 
Goodenough 1981) 
Cx31 
 
4 
 
2.5-3 
Hela cells (Diestel, Eckert et al. 2004) 
 
Mouse embryo hepatocytes (Traub, Look et 
al. 1987) 
 
 
Cx43 
 
 
 
 
 
1.5 
 
2.3 
 
 
2.5 
 
 
2 
 
Chicken lens epithelial cells (Musil, 
Cunningham et al. 1990) 
Bovine retinal endothelial cells (Fernandes, 
Girao et al. 2004) 
 
E36 Chinese hamster ovary cells (Laing and 
Beyer 1995) 
 
SK-HEP-1 cells 
 
Cx45 
 
Cx56 
4.2 
 
2-3 
HeLa cells (Hertlein, Butterweck et al. 1998) 
 
Chicken lens cultured cells (Berthoud, 
Bassnett et al. 1999) 
 
Table 1.4 The half-lives of few connexin isoforms in several cells or tissues. 
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 1.3.1. Connexin biosynthesis 
 
               Connexins are synthesized within the endoplasmic reticulum (ER) and co-
translationally inserted into ER membranes (Figure 1.2) (Zhang, Chen et al. 1996; 
Segretain and Falk 2004). Connexins are then transported to the plasma membrane via 
Golgi-apparatus (Figure 1.2) and trans-Golgi network (VanSlyke and Musil 2000). In the 
ER, connexins are synthesized with four transmembrane segments and are not 
glycosylated. Connexin oligomerization to connexon can take place in the ER or in the 
trans-Golgi network depending on the connexin isoform (Falk, Kumar et al. 1994; Falk 
and Gilula 1998; Ahmad, Diez et al. 1999; Maza, Das Sarma et al. 2005). Cx32 
oligomerizes in the ER (Kumar, Friend et al. 1995; Das Sarma, Wang et al. 2002). 
However, Cx43 and Cx46 have been found to be present in monomeric forms in the ER 
and Golgi apparatus and oligomerize in the trans-Golgi compartment (Musil and 
Goodenough 1993; Koval, Harley et al. 1997).  
               Upon exit from the ER, connexins pass through the Golgi apparatus to reach 
the trans-Golgi network. Several studies have documented that the role of the Golgi 
apparatus is to aid connexin transport (Laird, Castillo et al. 1995; Lauf, Giepmans et al. 
2002; Thomas, Telford et al. 2004; Thomas, Jordan et al. 2005). Few studies also show 
that connexins, mainly Cx26, can reach the plasma membrane via a Golgi-independent 
pathway (George, Kendall et al. 1999; Martin, Errington et al. 2001). Upon exiting the 
trans-Golgi network (TGN), connexins are delivered to the cell surface with the help of 
exocytic vesicles (Figure 1.2) (Jordan, Solan et al. 1999; Thomas, Jordan et al. 2005). 
The delivery process of connexins from TGN to cell membrane is aided by microtubules 
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that increase the efficiency of the delivery process (Feldman, Kim et al. 1997; Johnson, 
Meyer et al. 2002). When a connexon (hemichannel) arrives at the plasma membrane, it 
docks, head-to-head, with a hemichannel from adjacent cell to form the complete gap 
junction channel (Unger, Kumar et al. 1999; Lauf, Giepmans et al. 2002; Segretain and 
Falk 2004).  Gap junction channels cluster to form gap junctional plaques that may 
contain as many as 10,000 channels per plaque. In lens fiber cells, these gap junction 
plaques cover more than 50% of the cell surface (Musil 2009).  
 1.3.2. Connexin degradation 
  
               There is much evidence that suggests that connexins are degraded by 
lysosomal as well as proteasomal degradation pathways (Vaughan and Lasater 1992; 
Laing, Tadros et al. 1997). Degradation of connexins was found to be delayed in the 
presence of both lysosomal and proteasomal pathway in cell culture systems. During 
synthesis in the ER, misfolded or unfolded connexins are tagged with poly-ubiquitins 
and degraded via the endoplasmic reticulum associated degradation (ERAD) pathway, 
as a part of the process known as “quality control” (VanSlyke and Musil 2002). The 
pathway by which degradation of connexins, present at the cell surface, occurs has 
been under intense investigation in recent years and shows that mainly lysosome is 
involved (Figure 1.2). In this pathway, connexins at the surface are internalized into one 
of two adjacent cells as double-membrane structures, commonly known as annular 
junctions or connexosomes (Figure 1.2) (Jordan, Chodock et al. 2001; Leithe, Brech et 
al. 2006; Piehl, Lehmann et al. 2007; Nickel, DeFranco et al. 2008). Connexins are then 
trafficked to early endosomes, by a process which is not clearly understood but may 
18 
 
involve fusion of connexosomes to endosomes (Leithe, Kjenseth et al. 2009). 
Connexins are then delivered to late endosomes and ultimately to lysosomes where 
they are degraded (Figure 1.2) (VanSlyke, Deschenes et al. 2000; Qin, Shao et al. 
2003; Leithe, Sirnes et al. 2006). Various external factors such as changes in voltage, 
calcium concentration, stress and the phosphorylation of connexins by mitogen 
activated protein kinase (MAPK) or protein kinase C (PKC) have been implicated in the 
regulation of the internalization and degradation process in many cells (Leithe and 
Rivedal 2004; Solan and Lampe 2009).  
             Ubiquitination of connexins also acts as a major signal to mediate the Cx43 
degradation. Ubiquitin is a 76 amino acid protein that, upon multiple conjugation, 
(polyubiquitination) targets proteins to proteasomal pathway for degradation (Hershko 
and Ciechanover 1998). Laing et al (1995) first showed that ubiquitin was involved in 
the degradation of connexins when they found Chinese hamster ovary CHO-ts20 cells 
had increased levels of Cx43 when ubiquitin-activating enzymes were defective. 
Subsequent studies conducted in the last few years have established that Cx43 is 
ubiquitinated at the plasma membrane by E3 ubiquitin ligase Nedd4 (Figure 1.2) 
(Leykauf, Salek et al. 2006). Cx43 has a Nedd4 binding site (PY motif) at its C-terminal 
region (S282PPGY286) that binds to Nedd4 which is recruited by MAPK dependent 
pathway. The Nedd4 mediated ubiquitination leads to Cx43 degradation via the 
proteasome. 
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Figure 1.2 Intercellular trafficking of connexin.  
Connexins are synthesized within the ER and transported to the plasma membrane via 
Golgi-apparatus and trans-Golgi network. Connexins, at the cell surface, are 
internalized and degraded via lysosome. A E3 ubiquitin ligase Nedd4 ubiquitinates Cx43 
by the MAPK dependent pathway [Taken from Leithe 2007 with kind permission from 
Journal of Membrane Biology]. 
 
Studies in chapter 2 and 3 of this dissertation investigated the function of Cx46 
protein in lens and breast tumor tissues. Therefore  next section will address the cellular 
organization and gap junctions of lens. 
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 1.4. Lens 
 
               Vertebrate lens is a biconvex transparent organ whose main function is to 
focus the refracted light onto the retina. Lens is located at the anterior portion of the 
eye. At the anterior side of the lens is the aqueous humor and at the posterior side is 
the vitreous humor. The anterior surface of the lens is less curved than the posterior 
surface. 
 
 1.4.1. Cellular organization in lens 
 
               Vertebrate lens is composed of two types of cells, epithelial and fiber cells. 
Lens is surrounded by a basement membrane (capsule) that is elastic in nature and 
provides protective and contractive function to the lens. The lens can be broadly divided 
into three distinct regions based on cellular organization and presence of organelles: 
anterior epithelium, cortex and nucleus (Figure 1.3). The anterior surface of the lens is 
covered with a single layer of epithelial cells (Zampighi, Eskandari et al. 2000). These 
cells are hexagonal in morphology and their basal surface is in contact with the lens 
capsule that completely surrounds the lens. The lens epithelium contains most of the 
organelles and expresses most of the active transport proteins such as the Na-K 
ATPase pump. The epithelial cells at the anterior pole of the lens differ from the 
epithelial cells that reside in the equator in shape and property. The epithelial cells at 
the anterior pole are flat and do not divide (Gao, Sun et al. 2000). The epithelial cells, 
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located halfway between the anterior pole and equator, are cubic in shape and undergo 
mitosis. Cells at the equator are elongated with low mitotic activity and they eventually 
are differentiated to form differentiating fiber cells (DF) at the cortex region.  
The cortex region consists of two types of fiber cells, differentiating fiber cells at the 
outer side and the inner mature fiber (MF) cells (Zampighi, Eskandari et al. 2000). The 
central part of the lens is known as the nucleus. This region contains mainly mature 
fiber cells (Kuszak 1995).  
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Figure 1.3 Cellular organization of the lens showing capsule, epithelial monolayer 
at the anterior surface, cortical differentiating fiber cell (DF) and mature fiber cells 
(MF) and nuclear mature fiber (MF) cells.  
[Taken from Satyabrata Das PhD dissertation (2009) with kind permission].  
 
 1.4.2. Lens differentiation 
 
               As stated earlier, surface epithelial cells are differentiated into differentiating 
fiber cells (DF) at the equator region of the lens. This differentiation process is 
accompanied with changes in the expression of membrane proteins and upregulation of 
crystallins in the cytoplasm of DF. The transition from DF to mature MF occurs at the 
inner side of the cortex region. The mature fiber cell cytoplasm does not contain any 
organelles such as mitochondria, nuclei, Golgi bodies, endoplasmic reticulum and is rich 
in protein crystallins (Bassnett and Beebe 1992; Bassnett 1995). The crystallin proteins 
account for more than 85% of total proteins present in the lens. The differentiation of 
epithelial cells to DF is a continuous process and the lens grows throughout life. The 
newly synthesized fiber cells are deposited over the existing fiber cells at the surface 
pushing the old or existing fiber cells towards the center of the lens. The old fiber cells 
at the nucleus are as old as the organism itself. Several growth factors such as 
fibroblast growth factors (FGF) (Robinson, Overbeek et al. 1995), Wingless (Wnt) (Lyu 
and Joo 2004), transforming growth factor-B (TGF-β) proteins (de Iongh, Lovicu et al. 
2001), as well as several cell signaling pathways, including mitogen activated protein 
kinase (MAPK) signaling pathway (Wang, Stump et al. 2009), have been implicated to 
be involved in lens cell proliferation and differentiation. 
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 1.4.3. Lens gap junction 
 
               Vertebrate lens has two unique properties. First, the lens is hypoxic. The 
hypoxic nature of the lens will be discussed later. The second important characteristic of 
the lens is its avascular nature or absence of blood vessels. Therefore, lens 
homeostasis and cell-to-cell communication are mediated by a network of gap junctional 
intercellular communication (GJIC). Human lens endogenously expresses three 
connexin isoforms, connexin43 (Cx43), connexin46 (Cx46) and connexin50 (Cx50) 
(Goodenough 1992; Goodenough, Goliger et al. 1996; Donaldson, Kistler et al. 2001; 
Berthoud and Beyer 2009). The orthologs of these three connexins have been identified 
in human, mouse, rat, rabbit and chicken. These three connexin isoforms show distinct 
expression and spatial distribution inside the lens. Lens epithelium mainly contains 
Cx43 and Cx50. During epithelial-to-fiber cell differentiation, the Cx43 is significantly 
downregulated and Cx46 is highly upregulated in the fiber cells (Musil, Beyer et al. 
1990; Paul, Ebihara et al. 1991; Dahm, van Marle et al. 1999). Lens differentiation does 
not change Cx50 expression as high levels of Cx50 protein persist in both epithelial 
layers and DF and MF layers (White, Bruzzone et al. 1992).  
 1.4.3.1. Function of gap Junctions in lens 
 
               The gap junction channels formed by each of the three connexins show 
unique gating and permeability properties suggesting their important physiological roles 
in regulating the cell-to-cell communication at different regions of lens (White 2002; 
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White, Gao et al. 2007). Lens epithelial gap junctions are mainly composed of Cx43 and 
Cx50 whereas Cx46 and Cx50 gap junctional channels are present in DF and in MF 
(Beyer, Kistler et al. 1989; Paul, Ebihara et al. 1991; Jiang and Goodenough 1996). 
Cx46 and Cx50 form heteromeric connexons in the fiber cells. The fiber-epithelial 
junctions may be heterotypic channels composed of Cx43 and Cx46 (Mathias, Rae et 
al. 1997; Mathias, White et al. 2010). These three connexins have been shown to play 
significant roles in the proper lens development and differentiation. Among all the 
studies, mutational studies, in particular, have been able to shed more light on the 
functions of these connexins in lens. 
 
               The study of Cx43 function is greatly impeded by the fact that Cx43 knockout 
is lethal in mice (Reaume, de Sousa et al. 1995). However, lenses from Cx43KO pups 
have been isolated and studied (Gao and Spray 1998). Cx43 knockout, apparently, did 
not interfere with the normal lens development in the pups but intracellular large 
vacuoles appeared at the fiber cells. Lack of Cx43 expression also resulted in 
separation of epithelial cells and between epithelial cells and fiber cells suggesting a 
possible function of Cx43 in epithelial to fiber cell communication. 
 
       Cx46 plays a major role in maintaining fiber cell homeostasis. Cx46 channels 
are the major functional channels inside the center of the lens and are required in 
maintaining low intercellular Ca2+ concentration. It is speculated that the Cx46 channel 
cycles out Ca2+ from fiber cells to surface epithelial cells where the Ca2+ pumps are 
located. The support for this speculation came from the observations that Cx46 
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knockout mice developed severe cataracts at the nucleus of the lens with increased 
intercellular Ca2+ concentration (Gong, Li et al. 1997; Baruch, Greenbaum et al. 2001; 
Gao, Sun et al. 2004). The cataract is developed at the nuclear region of the lens with 
some opacity found at the cortical region (Figure 1.4C). The deletion of the Cx46 gene, 
however, does not inhibit normal lens development and growth. The increased 
intercellular concentration of Ca2+  in the fiber cells of Cx46 knockout mice activates 
Ca2+-activated calpain protease Lp82 (calpain 3) that cleaves and precipitates gamma-
crystallin protein resulting in cataract formation (Baruch, Greenbaum et al. 2001). 
Further support came from the work with Cx46/calpain3 double knockout mice where 
formation of cataract was found to be delayed significantly due to the absence of 
crystallin cleavage size (Shakespeare 2009). 
 
               Cx50 is also instrumental in lens development. Cx50 is the only connexin that 
is present in both epithelial and fiber cells. Deletion of Cx50 causes mild cataract (Rong, 
Wang et al. 2002; White 2002) (Figure 1.4 B) and significantly reduces lens growth that 
resulted from fewer, rather than smaller, lens fiber cells. Cx50 is required for lens cell 
proliferation at post natal stages. Cx50 knockout mice or Cx50KI46 (where one allele of 
Cx50 gene is replaced with Cx46) mice show reduced numbers of dividing cells during 
the first week of postnatal growth, indicating that Cx50 mediated communication is 
involved in the regulation of mitosis (Sellitto, Li et al. 2004). Cx46/Cx50 double knockout 
mice show severe cataract and significant reduction in lens size (Xia, Cheng et al. 2006) 
(Figure 1.4 D). Cx50/Calpain3 double knockout mice show absence of cataract and 
similar reduction in lens size (Shakespeare 2009). All these results suggest that Cx50 is 
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influential for maintaining proper lens growth whereas Cx46 acts to keep lens 
transparency.   
 
 
Figure 1.4 Images of lenses from normal wild-type, Cx50KO, Cx46KO, and 
Cx46/Cx50 double knockout mice emphasizing the importance of connexin genes 
for lens homeostasis. 
 (A). Wild-type lens which has normal size and clarity. (B). Cx50KO lens with mild 
nuclear cataract. (C). Cx46KO lens with normal size but severe dense nuclear cataract. 
(D). Cx46/ Cx50 double knockout lens with both a severe cataract and reduced lens 
size. [Taken from Shakespeare 2009 with kind permission from Springer eBook]. 
                                  
                    
This dissertation delves into the novel functions of Cx46 in breast tumor. 
Therefore the breast carcinogenesis and the roles that other connexins play in growth 
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and development of normal mammary gland and breast tumors will be reviewed in the 
next section. 
 1.5. Breast Cancer 
 
               Breast cancer is the most common form of cancer and the second leading 
cause of mortality in women around the world. Over 182,500 (female) and 1,990 (male) 
estimated new cases were reported in United States in 2008 (Jemal, Siegel et al. 2008). 
Due to the high mortality rate, breast cancer has been a subject of intense research for 
the last 10 years. 
   Two most significant risk factors for breast cancer are hormonal imbalance and 
hereditary susceptibility (Seidman, Stellman et al. 1982). Hormonal factors, mainly 
estrogen and progesterone, are the key regulators of breast cancer progression. 
Estrogen and progesterone are the two main hormones in the female body that are 
required for proper development. Estrogen causes breast cancer by inducing 
proliferation of existing mutant cells. These mutations are acquired through heredity or 
caused by environmental factors such as chemicals, radiation, cigarette smoking etc. 
Estrogen action inside the cells is mediated mainly by its cognate receptor, estrogen 
receptor α (ERα) (Katzenellenbogen, Montano et al. 2000; Sommer and Fuqua 2001). 
The interaction of estrogen with its receptor results in the dimerization of estrogen 
receptor and the formation of the ER-complex. The ER-complex exerts its effect by 
binding to the estrogen response element of several genes that collectively control the 
growth and proliferation of mammary epithelium (Levin 2005). About 70% of breast 
cancer cases are associated with overexpression of ER receptor (ER positive) (Fabris, 
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Marchetti et al. 1987). Aberrant expression of ER receptor causes estrogen mediated 
uncontrolled cell proliferation and DNA replication leading to mutations that promote 
breast tumorigenesis.  
               Hereditary factors include mutations in the two tumor suppressor genes, 
breast cancer susceptibility gene 1 (BRCA1) and breast cancer susceptibility gene 2 
(BRCA2) (Eisinger, Stoppa-Lyonnet et al. 1996; Robson, Gilewski et al. 1998; Choi, Lee 
et al. 2004). Mutations in this two genes account for less than 10% of the breast cancer 
cases and confer a lifetime risk of breast cancer of between 60-80% (King, Marks et al. 
2003). Current treatment of breast cancer includes surgery, radiation therapy and 
hormone blocking therapy with a drug tamoxifen.  
 1.5.1. Connexins in mammary gland development 
 
               Human mammary gland is an intricate organ that is composed of glandular, 
fatty and fibrous tissues. Mature mammary gland consists of a series of alveoli that are 
organized into milk producing glands called lobules (McLachlan, Shao et al. 2007). 
Each lobule is connected towards the nipple via ducts that transport milk from the 
lobules to the nipple. A single layer of luminal epithelial cells surrounds the ducts and 
alveoli and a basal myoepithelial cell layer surrounds the epithelium at the surface 
(Figure 1.5A). A layer of fatty tissue surrounds the breast glands and extends 
throughout the breast. The major development and differentiation of the mammary 
glands occurs post puberty. During involution and pregnancy, the mammary gland also 
undergoes extensive differentiation and remodeling to attain a lactating structure. From 
birth to post pregnancy, the development of mammary glands is regulated by the signal 
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pathways that include hormones, local growth factors and interactions between 
epithelial cells with surrounding stroma (Robinson, Karpf et al. 1999; Lamote, Meyer et 
al. 2004).  
               The gap junctional intercellular communication (GJIC) also plays a major role 
in the proper development, differentiation and functioning of vertebrate mammary 
glands at different stages of growth, from post-puberty to post-pregnancy. Human 
mammary glands have been shown to express two connexin isoforms Cx43 and Cx26 
(Lee, Tomasetto et al. 1991; Wilgenbus, Kirkpatrick et al. 1992). In addition to these 
connexins, mouse mammary glands have been found to express two more connexin 
isoforms, Cx30 and Cx32 (Pozzi, Risek et al. 1995; Locke, Perusinghe et al. 2000; 
Locke, Jamieson et al. 2007). The expression, localization and channel formation of all 
these connexins are distinct and controlled in a precise manner throughout the 
mammary gland development.    
 
                 Cx26 is the first connexin identified in human mammary glands. Several 
studies have shown that Cx26 channels are predominantly located in between the 
luminal cells (Figure 1.5B) indicating its selective function in luminal cell proliferation 
(Talhouk, Elble et al. 2005). Another connexin, Cx43, is found to form gap junction 
channels only between myoepithelial cells (Figure 1.5B) and is speculated to maintain 
myoepithelial differentiation in resting human mammary gland                                                                                                                                                                                                                                                                                                           
(Talhouk, Elble et al. 2005). In mouse, two other connexins Cx30 and Cx32 are also 
expressed in the luminal cells (Figure 1.5B) during lactation (Monaghan, Perusinghe et 
al. 1994; Pozzi, Risek et al. 1995). The expression of Cx30 and Cx32 are not detected 
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in human mammary glands which indicates that these connexins may have a distinct 
function in mouse mammary glands that is either compensated or not required in human 
counterparts.  
 1.5.2. Functions of connexins in mammary gland 
 
                The mammary glands gap junction channels formed by different connexins 
have distinct functions. Northern blot and microarray studies have shown that Cx26 
mRNA is detected in the mouse mammary gland during lactation (Locke, Stein et al. 
2004), pregnancy as well as in all stages of development. The expression of Cx26 
protein goes up during lactation and declines in involution (Talhouk, Elble et al. 2005). 
At early stages of mammary gland development, Cx26 functions in luminal epithelial cell 
proliferation and, in later stages of development, along with Cx32, Cx26 is required for 
the proper production of milk by secretory cells (McLachlan, Shao et al. 2007). Inhibition 
of Cx26 expression in the mammary epithelium, before puberty, results in impaired 
lactation and development (Bry, Maass et al. 2004). Like Cx26, Cx30 expression also is 
increased at the onset of lactation and decreased in involution in mouse. 
Immunohistochemical studies have detected Cx32 at all stages of development 
indicating its importance in the regulation of mammary gland growth in mouse (Talhouk, 
Elble et al. 2005).  
 
               Mammary gland connexins, Cx26 and Cx32, can compensate for each other’s 
function (Locke, Stein et al. 2004). Conditional knockout of Cx26, during pregnancy, 
does not affect the normal mammary gland function. Similarly, Cx32 null mice are 
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associated with proper mammary gland development and functioning. A study, done by 
Locke et al (2004), shows that gap junction channels can be formed by hetero-hexamer 
containing Cx26 and Cx32, in the luminal epithelial cells, during the later stage of 
pregnancy with stoichiometric ratio greater for Cx26. During lactation the ratio of Cx32 
increases within the hexamer and eventually homomeric Cx32 is formed. The change of 
Cx26-Cx32 connexon to Cx32 connexon is speculated to be in accordance with the 
cell’s biological need. Channels formed by Cx32 alone are much wider than the 
heteromeric Cx32-Cx26 channels and allow the free passage of larger molecules such 
as cAMP and cGMP (Bevans, Kordel et al. 1998; Weber, Chang et al. 2004), the 
metabolites that act in the several pathways involved in the regulation of mammary 
gland growth and differentiation.  
 
              The function of Cx30 has not been investigated to date and elucidation of the 
function of Cx43 is impaired due to the fact that Cx43 knockout is lethal in mouse 
embryos (Reaume, de Sousa et al. 1995). However some studies with knock-in 
technology shed light on the role of Cx43 in breast development. Heterozygous 
Cx43KICx32 mice (where an allele of Cx43 gene is replaced with Cx32 allele) show 
normal milk production but impaired milk ejection indicating a possible role of Cx43 in 
the functioning of the mammary gland (Plum, Hallas et al. 2000).  
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Figure 1.5 The microanatomy of mammary gland with expression and localization 
of different connexins.  
(A). Structural organization of mammary gland with duct, alveolus, myoepithelial cell 
layer and luminal cells. (B). The localization of connexins in human and mouse 
mammary gland. [Figure reprinted from McLachlan 2007 with kind permission from the 
Journal of Membrane Biology]. 
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 1.5.3. Connexin and breast tumor 
 
               Cx26 and Cx43 are well-documented for their tumor-suppressive roles in 
several carcinomas, including breast tumors. Cx26 and Cx43 are deemed breast tumor 
suppressors since 1991 when Lee et al first identified them as the candidates for tumor 
suppressor genes by subtractive hybridization techniques. However, till today, the 
correlation of expression of connexins with the function as a tumor suppressor at 
different stages of breast carcinogenesis is far from clearly understood and is often 
contradictory. Breast tumor progression is generally accompanied with a loss of gap 
junctional intercellular communication when compared to the matched normal tissues 
(Wilgenbus, Kirkpatrick et al. 1992; Laird, Fistouris et al. 1999; Kanczuga-Koda, 
Sulkowski et al. 2006). The loss of communication of tumor cells with the neighboring 
normal cells, due to defective or lack of GJIC, promotes tumor progression. Studies in 
the early 90s detected low levels of Cx26 and Cx43 mRNA in the primary cells derived 
from human breast tumors and several breast cancer cell lines (Laird, Fistouris et al. 
1999; Singal, Tu et al. 2000). The reason for the repression of Cx26 gene in breast 
tumors is clearly not known, though occurrence of methylation at the promoter region 
could contribute to the gene silencing (Singal, Tu et al. 2000; Tan, Bianco et al. 2002). 
Support from this notion came from the work of Singal et.al. (2000) where they found 
that Cx26 is hypermethylated in MCF-7 breast cancer cells leading to gene silencing 
and reduced expression. Another study with tumor tissues from breast cancer patients 
reported that the Cx26 promoter was methylated in more than 50% of the tissues 
irrespective of the stage of cancer (Tan, Bianco et al. 2002).  
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               Cx43 protein expression was also found to be downregulated in human tumor 
tissues as well as in several breast cancer cells when compared to their normal 
counterparts. Laird et al., (1999) showed that reduced Cx43 expression can be used as 
an independent marker for the detection of breast tumors. Lack of Cx43 gap junctions 
was observed in ductal carcinomas in situ, infiltrating ductal carcinomas, and infiltrating 
lobular carcinomas with no correlation with the level of estrogen and progesterone, the 
hormones that regulate Cx43 expression. However, there are also few reports made on 
the occurrence of connexin upregulation in breast tumor. One study reports that 50% of 
invasive carcinomas express Cx43 (Jamieson, Going et al. 1998). In these samples 
Cx43 were only detected in the cytoplasm and the presence of gap junctions were not 
observed. Jamieson et al (1998) also showed that Cx26 expression was detected in 
75% of breast ductal carcinoma in situ, a value which is much higher relative to normal 
breast tissues. Another study reported increased expression of Cx26 and Cx43 in lymph 
node metastases (Naoi, Miyoshi et al. 2007). One common observation, in all the above 
studies, was that connexins were typically retained within the cytoplasm and not 
localized at cell surfaces to mediate their gap junctional function.  
 
 
 
 1.5.3.1. Effect of re-expression of connexins in cancer (breast) 
 
               Several reports have been made on the inhibition of tumor growth upon 
reconstitution or re-expression of Cx26 or Cx43 in breast cancer cells (McLachlan, Shao 
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et al. 2007). Re-expression of Cx43 or Cx26 resulted in growth suppression and 
reversed the malignancy of human mammary carcinoma cell, MDA-MB-435 (Hirschi, Xu 
et al. 1996). Re-expression of Cx26 reduced the levels of total ß1 integrin, and 
the matrix metalloproteinase-9 (MMP-9) activity. Similarly, overexpression of Cx43 in 
MDA-MB-231 cells though did not effect in vitro cell proliferation but inhibited the tumor 
growth in mice (Qin, Shao et al. 2002). Transfection of C6 glioma cells with Cx43 (Zhu, 
Caveney et al. 1991; Bond, Bechberger et al. 1994) and the transfection of human 
hepatoma cell, SKHep1, with Cx32 (Eghbali, Kessler et al. 1991) suppressed the growth 
of both transfected cells and xenograft-tumors in nude mice. Transfection of liver 
carcinoma HepG2 cells with Cx26 changed the morphology of the cells and decreased 
xenograft tumor growth (Yano, Hernandez-Blazquez et al. 2001).  
   
               In most of the studies, mentioned above, the restoration of connexin 
expression in the tumor cells did not result in gap junction formation (Kalra, Shao et al. 
2006) and therefore the suppression of tumor growth is speculated to be mediated by 
mechanisms independent of GJIC. The GJIC independent roles of connexins have also 
been found in the regulation of apoptosis. Kanczuga-Koda et al (2005) found that Cx26 
and Cx43 expression correlated with proapoptotic factor Bak but not with Bcl-2. Cx26 
and Cx43 are also considered to be involved in the inhibition of angiogenesis in breast 
cancer. Cx26 was found to inhibit angiogenesis via mechanisms that are both GJIC 
dependent and independent. Overexpression of a functional or a non-functional Cx26 
variant upregulated the expression of an anti-angiogenic molecule, thrombospondin-1 
(TSP-1), in MDA-MB-435 cells (Qin, Shao et al. 2003). Similarly, downregulation of 
Cx43, by a siRNA, reduced the expression of angiogenesis inhibitor TSP- 1 and 
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resulted in an aggressive cell phenotype of breast cancer Hs578t cells (Shao, Wang et 
al. 2005). A similar result was found by another group (McLachlan, Shao et al. 2006) 
when they observed that MDA-MB-231 cells, overexpressing Cx26 or Cx43, showed 
increases in the expression of anti-angiogenic factors over pro-angiogenic molecules.  
 
               The mechanisms by which connexins act as tumor suppressors are yet to be 
identified at the molecular level. The majority of the data, to date, indicates that 
connexins suppress tumor growth by GJIC- independent mechanisms. Most of the 
studies are done using in vitro cell culture systems, where the environments are not the 
actual representation of in vivo conditions. Another important question that is yet to be 
fully answered; does the loss of GJIC promotes tumor progression or is it a 
consequence of it? Therefore more elaborate investigations are required to ascertain 
the role of connexins in tumorigenesis. 
 
               This dissertation investigates hypoxia-specific function of connexin46 and 
therefore the roles that hypoxia or hypoxia regulated pathways play in lens and breast 
carcinogenesis will be reviewed below. 
 
 1.6. Hypoxia 
 
               Hypoxia refers to the condition of reduced availability oxygen. In tissue, 
hypoxia is a pathological condition, known as ischemia, which arises due to the lack of 
proper blood flow that results in reduced oxygen and nutrients supply to the cells. 
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Hypoxia is involved in the development of several life-threatening diseases such as 
tumorigenesis, kidney disease, pulmonary hypertension, inflammation and Alzheimer 
disease and therefore, it has been a subject of intense scientific research for centuries.  
 
 1.6.1. Hypoxia and lens 
 
               A unique property of lens is its hypoxic nature. Lens is one of the natural 
hypoxic tissues in the human body. Several studies have reported that the oxygen 
concentration in the cortical region of lens is below 5% and around (or below) 1% in the 
nucleus (Helbig, Hinz et al. 1993; McNulty, Wang et al. 2004; Shui, Fu et al. 2006; 
Beebe 2008; Shui and Beebe 2008). Lens is also located at the low oxygen 
environment of the anterior segment of the eye. The average PO2 in the aqueous humor, 
which is located at the anterior side of the lens, of rabbit eye is 38 mm Hg (Fitch, 
Swedberg et al. 2000) and in the vitreous humor (posterior side of the lens) of human 
eye is 16 mm Hg (Sakaue, Negi et al. 1989; Maeda and Tano 1996). These PO2 values 
are much smaller than, for example, the PO2 in arteries which is 100 mm Hg. The PO2 
value at the anterior region, which is immediately adjacent to the lens, was found to be 
2-3 mm Hg in cat, chicken and rabbit eyes (Jacobi and Driest 1966; Ormerod, Edelstein 
et al. 1987; Bassnett and McNulty 2003). 
 
               The lens requires hypoxia to maintain its growth and optimum transparency. 
Exposure of lens to higher concentrations of oxygen leads to oxidation and precipitation 
of crystallin proteins that results in increased light scattering and ultimately in the 
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development of nuclear cataract (Dische and Zil 1951; Palmquist, Philipson et al. 1984; 
Giblin, Padgaonkar et al. 1995; Holekamp, Shui et al. 2006). Low oxygen suppresses 
the growth of the epithelial cells which is essential to maintain the proper growth and 
size of the lens in vertebrates. A study by Shui et al (2008) showed that the lenses of 
one-month old rats contained low levels of oxygen. The lens cell proliferation and lens 
growth declined with low oxygen concentration after one-month of growth of those rats. 
If the oxygen concentration was elevated to 60% the lens growth also increased. It 
suggests that hypoxia is essential to maintain the proper growth and size of the lens in 
vertebrates. Low oxygen is speculated to control lens growth by inhibiting synthesis or 
secretion of growth factors in the intraocular fluids and by suppressing epithelial cell 
response to the growth factors. 
 1.6.2. Hypoxia and tumor (breast) 
 
               Hypoxia is an important feature of solid tumor growth. Hypoxia arises 
due to the lack of blood vessel formation around the developing mass in a solid tumor. 
Impaired blood supply, due to the inadequate vascularization, results in very low oxygen 
concentration inside the tumor (Brizel, Rosner et al. 1995). Studies, where the oxygen 
measurement was done by needle electrode, showed that the oxygen concentration can 
go down as low as 1% inside the solid breast tumor (Vaupel, Kallinowski et al. 1989; 
Vaupel, Schlenger et al. 1991). Breast tumors use hypoxia as an adaptation to grow 
and survive. The role of hypoxia in the progression of breast carcinogenesis has been 
studied extensively. Hypoxia brings about changes in the morphological and 
physiological characteristics of the cells to shift the balance towards tumor progression 
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over tumor regression during tumorigenesis. Hypoxia alters the gene expression of 
several signaling pathways including angiogenesis, apoptotic and glycolytic, to promote 
breast tumor progression and malignancy (Knowles and Harris 2001). 
 1.6.1.1. Hypoxia and tumor angiogenesis 
 
               Hypoxia favors primary tumor growth by promoting angiogenesis to increase 
the blood vessel formation around the developing tumor. Hypoxia significantly 
upregulates the pro-angiogenic molecule vascular endothelial growth factor (VEGF) and 
its receptor flk-1 (Shweiki, Itin et al. 1992; Carmeliet 2000). Hypoxia exerts its effect at 
the gene level by inducing transcription factor hypoxia inducible factor-alpha 1 (HIF-1α).  
HIF-1α is a part of a heterodimer HIF-1. In normoxic condition, an enzyme prolyl 
hydroxylase converts HIF-1α to a hydorxylated form that interacts with the tumour 
suppressor Von Hippel–Lindau (VHL) protein (Figure 1.6). VHL is part of a larger 
complex that contain ubiquitin-conjugating enzyme (E2). This complex, with the help of 
a ubiquitin-activating enzyme (E1), mediates the ubiquitylation (Ub) of HIF-1α and 
subsequent proteasomal degradation. During hypoxia, prolyl hydroxylase cannot modify 
HIF-1α allowing it to remain stable. Stabilized HIF-1α s then translocates to the nucleus 
and interacts with cofactors such as aryl hydrocarbon receptor nuclear translocator 
(ARNT), CBP/p300 and the DNA polymerase II (Pol II) complex (Figure 1.6). This large 
complex then binds to hypoxia-responsive element (HREs) and activates transcription 
of the target genes including VEGF. HIF-1α has been found to be upregulated in a 
broad range of human malignancies including primary breast cancers (Bos, van der 
Groep et al. 2003; Semenza 2003). Several studies have also shown that HIF-1α can 
40 
 
induce other angiogenetic factors interleukin-1(IL-1) (Shreeniwas, Koga et al. 1992), 
erythropoietin (Goldberg, Dunning et al. 1988) and platelet derived growth factor 
(PDGF) (Deberardinis, Sayed et al. 2008). 
 
 
 
Figure 1.6 The molecular mechanism of hypoxia mediated activation of HIF-1α.  
In presence of oxygen (normoxia) the enzyme prolyl hydroxylase modifies HIF-1α to 
interact with Von Hippel–Lindau (VHL) protein. This interaction mediates ubiquitination 
of HIF-1α and subsequent degradation. In presence of low oxygen (hypoxia), prolyl 
hydroxylase is inactivated and thus no longer modifies HIF-1α allowing it to remain 
stable. Stabilized HIF-1α then translocates to the nucleus and with the help of other 
proteins, binds to the hypoxia-responsive element (HRE) and induces the target gene 
transcription. [Figure reprinted from Harris, 2002 with kind permission from the journal 
Nature Reviews of Cancer]. 
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 1.6.1.2. Hypoxia and apoptosis 
 
               One of the hypoxia mediated signal pathways that kill normal cells is apoptosis 
(Malhotra, Lin et al. 2001). Howver, in tumor cells, hypoxia inhibits apoptotic pathway to 
prolong their survival. In liver tumor cells (HepG2), hypoxia inhibits apoptosis, reduces 
mitochondrial permeability and cytochrome c release in the cytoplasm, decreases the 
activity of the downstream component, caspase 3, and also reduces the pro-apoptotic 
bax to anti-apoptotic bcl-2 ratio (Baek, Jang et al. 2000). Another mechanism by which 
cells can escape hypoxia-induced apoptotic death is by the process of selection and 
clonal expansion of the cells with mutations in the components of the apoptotic pathway 
(Graeber, Osmanian et al. 1996). When oncogenically transformed mouse embryonic 
fibroblast cells were treated with hypoxia, cells with no pro-apoptotic protein p53 (p53-/-) 
were selected over wild type cells. It was also observed that little apoptosis occurred in 
the hypoxic regions of p53 deficient murine tumors whereas high levels of apoptosis 
occurred in the highly hypoxic regions of p53 wild type tumors. p53-/- cells are apoptotic 
resistant cells due to the deletion of the p53 pro-apoptotic gene. Therefore, it is 
speculated that, in the primary tumor tissues, the hypoxic environment contributes to 
malignancy by passively selecting the cells with acquired mutation that confers 
resistance to the apoptotic death. 
 1.6.1.3. Hypoxia and the glycolytic shift 
 
               Another major change in tumor cells, in response to hypoxia, is the shift of the 
respiratory pathway to anaerobic glycolysis. The presence of low oxygen reduces the 
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ATP production via the electron transport chain and therefore, hypoxic tumors attain 
their metabolic need via an increased glycolytic pathway. Therefore, one of the 
characteristics of rapidly growing tumor is a high rate of glucose consumption (Vaupel, 
Kallinowski et al. 1989). Hypoxia activates the expression of several glycolytic enzymes 
including phosphoglycerate kinase1, lactate dehydrogenase A, pyruvate kinase M, 
glyceraldehyde-3-phosphate dehydrogenase, enolase1 and aldolase A (Semenza, Roth 
et al. 1994). Low oxygen also regulates the expression of the glucose transporter 
genes, glut1 and glut3, in human tissues to maximize glucose uptake (Maxwell, Dachs 
et al. 1997). All of these adaptations enable tumor cells to maximally utilize glucose for 
efficient energy production that aids tumor cells to grow under the adverse conditions 
where normal cells cannot.  
 1.7. Connexin46 (Cx46) 
 
               As mentioned earlier, Cx46 is a connexin protein with predicted molecular 
weight of 46 kDa. The Cx46 protein is expressed in human and orthologs are found in 
rabbit, rat, bovine and chicken. The rat Cx46 is a 416 amino acid long protein with four 
transmenbrane domains (residues 20-42, 77-99, 155-177 and 207-229). It has a short 
N-terminal (about 20 amino acid) and a relatively long C –terminal tail (about 187 amino 
acid), both of which reside at the cytoplasm. Among the members of connexin family 
isoforms, connexin 43 (Cx43) has been studied most extensively. There are more than 
2000 published article covering different aspects of Cx43 life cycle including synthesis, 
degradation, post-translational modification and function. Some of the reasons that 
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Cx43 has been well-studied are its endogenous expression in over 30 distinct animal 
tissues and its role as a potent tumor suppressor.  
 
               In contrast to Cx43, Cx46 has not been extensively studied. Though Cx46 
primary transcripts have been found in many mice tissues (Anderson, Zundel et al. 
2005) the actual protein expression have only been reported, to my knowledge, in 
vertebrate lens (Donaldson, Kistler et al. 2001), lung adenoma (Avanzo, Mesnil et al. 
2006) and lung alveolar cells (Abraham, Chou et al. 1999), Schwann cells (Chandross 
1998) and bone osteoblastic cells (Koval, Harley et al. 1997). The gap junctional 
function of Cx46 in lens has been investigated previously. As mentioned earlier, Cx46 
gap junction channels are required to maintain Ca2+ homeostasis inside the lens. 
However the function of Cx46 in other tissues including tumor has not been 
investigated. Cx46 was highly expressed at urethane-induced mouse lung adenomas 
though the proper function was not reported (Avanzo, Mesnil et al. 2006). Cx46 proteins 
had been found to be localized to intercellular compartments in bone osteoblastic cells 
(Koval, Harley et al. 1997) and upregulated in Schwann cells after nerve injury 
(Chandross 1998). 
 
               The lens is a naturally hypoxic tissue in an animal body. But how the lens 
survives against the all adversity of low oxygen is not well-known. Initially, we have 
found that Cx46 protein is also highly expressed in early hypoxic breast tumor tissues. 
In my dissertation work, I have studied the role of Cx46 in a natural hypoxic tissue, lens 
and a diseased hypoxic tissue, breast tumor. I have found that Cx46 provide protection, 
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to both lens and breast tumor, against hypoxia-induced death and regulates the 
degradation of Cx43 in lens. The findings of my research have been presented in 
Chapter 2 and 3 of the thesis. 
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CHAPTER 2 - A novel role of gap junction connexin46 
protein to protect breast tumors from hypoxia  
 2.1. Introduction 
 
               Gap junctions are intercellular membrane channels that maintain direct 
intercellular communication through the exchange of ions, small molecules and cellular 
metabolites between neighboring cells. Gap junction channels are formed through the 
hexameric oligomerization of transmembrane proteins called connexins (Goodenough, 
Goliger et al. 1996). Over the years, several studies have shown that the gap junctions 
are involved in the regulation of important cellular processes including cellular 
homeostasis, cell growth and differentiation, morphogenesis and cell death 
(Loewenstein 1979). 
    For more than 40 years, the loss of gap junction communication has been 
shown to be an important step in the development of carcinoma (Trosko and Ruch 
1998). There is also increasing evidence that loss of connexin protein expression or 
dysfunction of gap junction intercellular communication (GJIC) is associated with breast 
cancer malignant progression (Lee, Tomasetto et al. 1991; Laird, Fistouris et al. 1999; 
Kanczuga-Koda, Sulkowska et al. 2003). The connexins, well-documented for tumor-
suppressive functions in breast carcinoma, are  connexin43 (Cx43) and connexin26 
(Cx26) (Lee, Tomasetto et al. 1992; Hirschi, Xu et al. 1996; Qin, Shao et al. 2002; 
Kanczuga-Koda, Sulkowski et al. 2005; Shao, Wang et al. 2005). These connexins are 
required for differentiation and proper development of normal mammary gland. Studies 
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have shown that Cx26 and Cx43 were downregulated at the mRNA and protein level in 
human breast tumors and several human mammary tumor cell lines (Lee, Tomasetto et 
al. 1992). Re-expression of Cx26 or Cx43 reverses the malignancy of human mammary 
carcinoma cells MDA-MB-435 (Hirschi, Xu et al. 1996). Similarly, overexpression of 
Cx43 in MDA-MB-231 cells inhibits the tumor growth in mice (Qin, Shao et al. 2002). 
Cx43 is also considered to be involved in the inhibition of angiogenesis in breast cancer. 
For instance, downregulation of Cx43 by siRNA in breast cancer Hs578t cells results in 
the reduced expression of angiogenesis inhibitor thrombospondin-1 (TSP-1) and in 
aggressive cell phenotype (Shao, Wang et al. 2005). 
 
               Another important feature in breast carcinoma is adaptation to hypoxia that 
favors tumor growth and survival. Several studies have shown that the inside oxygen 
levels, in a solid breast tumor, can go down as low as 1% (Vaupel, Schlenger et al. 
1991; Vaupel, Briest et al. 2002). Hypoxia which arises due to lack of formation of new 
blood vessels in a developing tumor mass induces hypoxia-inducible factor-1α (HIF-1α) 
(Wang, Jiang et al. 1995). HIF-1α is a key transcription factor that activates gene 
expression of pro-angiogenic factor vascular endothelial growth factor (VEGF) (Maxwell, 
Dachs et al. 1997). In solid tumors, HIF-1α also induces expression of other growth 
factor such as transforming growth factor-β and platelet-derived growth factor to 
promote cell proliferation (Denko, Schindler et al. 2000; Koong, Denko et al. 2000; 
Wykoff, Pugh et al. 2000). Hypoxia also regulates the gene expression of several other 
signaling pathways including apoptosis and glycolysis to enhance tumor progression 
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and metastasis (Semenza, Roth et al. 1994; Van Meir 1996; Baek, Jang et al. 2000; 
Chandel and Simon 2008). 
 
  There is another tissue that is naturally hypoxic, vertebrate lens. The oxygen 
concentration in the cortical region of lens is below 5% and around (or below) 1% in the 
nucleus (McNulty, Wang et al. 2004; Holekamp, Shui et al. 2005; Holekamp, Shui et al. 
2006; Shui, Fu et al. 2006). Lens requires hypoxia to prevent opacification and maintain 
optimum transparency (Beebe 2008; Shui and Beebe 2008; Akoyev, Das et al. 2009). 
However, how lens survives against the all adverse effects of hypoxia is not well known. 
Lens tissue endogenously express 3 connexin isoforms Cx43 (α1), Cx50 (α8) and Cx46 
(α3) (Goodenough 1992; Goodenough, Goliger et al. 1996; Donaldson, Kistler et al. 
2001; Rong, Wang et al. 2002). Connexin46 (Cx46, Mw ∼ 46 kD) is preferentially 
expressed in lens fiber cells, inside the even more hypoxic center of the lens (Tenbroek, 
Arneson et al. 1992). Cx46 is believed to be essential for maintaining proper Ca2+ 
homeostasis in fiber cells to prevent cataract formation. Cx46 knockout mice show a 
marked increase in nuclear cataract (Gong, Li et al. 1997)with increased Ca2+. 
 
               The role of Cx46 in tissues other than lens has not been extensively 
investigated. Though Cx46 primary transcript was detected in several mouse tissues but 
actual protein expression has been reported only in lung adenoma and lung alveolar 
cells (Abraham, Chou et al. 1999; Avanzo, Mesnil et al. 2006), Schwann cells 
(Chandross 1998) and bone osteoblastic cells (Koval, Harley et al. 1997). Cx46 is highly 
expressed at urethane-induced mouse lung adenomas though the proper function was 
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not reported (Avanzo, Mesnil et al. 2006). In this study, I investigated a novel role of 
Cx46 protein to protect cells from hypoxia-induced death. I found that Cx46 protein is 
highly expressed in MCF-7 breast cancer cells and human breast tumors. I 
hypothesized that the presence of Cx46 protein aids breast tumors' growth and also 
lens homeostasis under hypoxia. Downregulation of Cx46 in hypoxia-resistant human 
lens epithelial cells (HLEC) and MCF-7 breast cancer cells confers susceptibility to 
hypoxia. In contrast, overexpression of Cx46 in hypoxia-sensitive neuronal gap junction 
deficient N2A cells endows resistance against hypoxia. Further studies demonstrated 
that knockdown of Cx46 in vivo inhibited human breast tumor xenograft growth in nude 
mice. Thus Cx46, unlike other connexins, may play a significant role in the growth and 
development of early hypoxic breast tumors and, in the natural hypoxic lens 
 
 
 2.2. Methods and Materials 
 2.2.1. Reagents 
 
               Dulbecco’s modified Eagle’s medium (DMEM; low glucose), trypsin-EDTA, 
gentamicin, and penicillin/streptomycin were purchased from Invitrogen Corp. 
(Carlsbad, CA). Bovine serum albumin (BSA) and dithiothreitol (DTT) were purchased 
from Fisher Scientific (Hampton, NH). Fetal bovine serum was purchased from Atlanta 
Biologicals (Norcross, GA, # S11050). RIPA buffer (10X) was purchased from Cell 
Signaling Technology (Boston, MA, #9806). Protease inhibitor cocktail (# P8340) was 
purchased from Sigma-Aldrich (St. Louis, MO). Phosphatase inhibitor cocktail (# 
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524625) was purchased from Calbiochem (La Jolla, CA). SuperSignal West Femto 
chemiluminescence substrate kit (#1856136) was purchased from Pierce (Rockford, IL). 
 
 2.2.2. Antibody 
 
              Rabbit polyclonal anti-Cx46 antibody was purchased from USBiological 
(Swampscott, MA, #C7858-07A). Mouse Anti-Cx50 (#33-4300), mouse anti-Cx26 (#13-
8100) and mouse anti-α-tubulin antibodies were purchased from Zymed-Invitrogen 
(Carlsbad, CA).  Mouse anti-β-actin antibody was purchased from Sigma (St. Louis, 
MO). Secondary anti-mouse IgG (#31430) and anti-rabbit IgG (#31460) conjugated with 
horseradish peroxidase were purchased from Pierce (Rockford, IL). 
 
 2.2.3. Cell culture and transfection 
 
               NN1003A rabbit lens epithelial cells, human lens epithelial cells (HLEC) 
and mouse neuronal N2A cells were cultured in Dulbecco's modified Eagle's medium 
(DMEM, low glucose; Invitrogen, CA) supplemented with 10% fetal bovine serum and 
50 µg/mL gentamicin, 0.05 U/mL penicillin, and 50 μg/mL streptomycin , pH 7.4 at 37OC 
in an atmosphere of 90% air and 10% CO2. Breast cancer MCF-7 (Human breast 
adenocarcinoma cell) cells were purchased from American Type Culture Collection 
(ATCC, Manassas, VA). MCF-7 cells were grown in Minimal Essential Media (MEM, 
ATCC, # 30-2003) supplemented with 0.01 mg/ml bovine insulin and fetal bovine serum 
to a final concentration of 10%. 
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                To generate stably transfected neuronal N2A cells overexpressing Cx46 or 
Cx43 the cDNA of rat Cx46 (Figure 2.1) or rat Cx43 (NCBI Reference Sequence: 
NM_012567.2) was sub-cloned into pEGFP-N3 vector (Clontech, Mountain View, CA) at 
the EcoR1 and BamH1 restriction sites in the proper reading frame with GFP coding 
sequences (Figure 2.2) and transfection was carried out using Lipofectamine 2000 
(Invitrogen, Carlsbad, CA). The selection of transfected cells was done by growing cells 
in the presence of G418 antibiotic (500 µg /ml) for 6 weeks. The expression of Cx46-
GFP and Cx43-GFP proteins in stably transfected cells were confirmed by western blot 
analyses using anti-GFP antibody. 
 
Figure 2.1 The cDNA sequence of rat Cx46 obtained from  www.ncbi.nlm.nih.gov 
(NCBI Reference Sequence: NM_024376.1) 
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Figure 2.2 Restriction map and multiple cloning sites (MCS) of pEGFP-N3 vector 
(GenBank Accession #: U57609).  
The rat cDNA of Cx46 and Cx43 was sub-cloned into EcoR1/BamH1 sites. 
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 2.2.4. Whole cell homogenate preparations (WCH) 
  
               Cells were washed 3 times with cold phosphate-buffered saline (PBS, 137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4 and a pH of 7.4), collected by 
scraping from plates and centrifuged at 4000 rpm for 5 min at 4OC. The cell pellets were 
lysed in ice cold 1X RIPA buffer [10 mM Tris-HCl (pH 7.5),150 mM NaCl, 1 mM 
Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium 
pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na3VO4,  1 µg/ml leupeptin] 
containing 1 mM PMSF. Cell lysates were sonicated for 10 sec (3 times) and protein 
concentration of each sample was measured using Bio-Rad Protein Assay. 
 
 2.2.5. Western blot and densitometric analyses 
 
               Equal amounts of total protein in cell lysates were run into 10% SDS-PAGE 
and transferred to a nitrocellulose membrane (OPTI TRAN, Midwest Scientific, St. 
Louis, MO). The membrane was incubated with anti-Cx46 antibody for 6 hr at room 
temperature. For all other antibodies, the blot was incubated with primary antibody for 
overnight at 4OC. The dilutions of the antibodies used are as follows; Anti-Cx46 
antibody: 1:500, anti-Cx43 antibody: 1:8000, anti-GFP antibody: 1:2000, anti-tubulin 
antibody: 1:5000 and anti-β-actin antibody: 1:10000. The membrane then washed with 1 
X TDN buffer (1 M NaCl, 0.2 N Tris, 0.04 M EDTA, pH 7.4) for 10 min, 3 times, and 
incubated with secondary anti-mouse IgG or anti-rabbit IgG (dilution 1:1500) conjugated 
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with horseradish peroxidase for 2 hr at room temperature. The membrane was again 
washed with 1 X TDN for 15 min, 4 times and then incubated with substrate 
SuperSignal West Femto Substrate kit (Pierce, Rockford, IL) followed by exposure to X-
ray film (Midwest Scientific, St. Louis, MO). 
 
              For densitometric analysis the X-ray film was scanned and bands were 
digitized using UN-SCAN-IT software (Silk Scientific, Inc, Orem, Utah). The average 
pixel values were calculated for each Cx46 bands, normalized against average pixel 
values for loading control (tubulin or β-actin) and plotted in percentage (%) of control. 
 2.2.6. Reverse Transcriptase (RT)-PCR 
 
          RT-PCR analyses were performed by Dr. Gunjan Gakhar at Dr. T. A .Nguyen’s 
lab, Department of Diagnostic Medicine/Pathobiology, Kansas State University. In brief, 
total RNA was purified from HMEC, MCF-7 and HLEC (human lens epithelial cells) 
using RNeasy Mini Kit (Qiagen, Valencia, CA) and RT-PCR was performed using one-
step RT-PCR kit (Qiagen) according to the instruction manual with Cx46 cDNA specific 
primers and β-actin cDNA specific primers as control. The primers for Cx46 cDNA were 
5′-CTG GCC CTG CTG GCC TTG-3′ and 5′-CCA CCA CCT GCT GAT GAC-3′. The 
primers for β-actin were 5′ -GAA ATC GTG CGT GAC ATT AAG-3′ and 5′-CTA GAA 
GCA TTT GCG GTG GAC GAT-3′. For PCR, initial activation was done at 95O C for 15 
min, denaturation at 95O C for 30 sec, annealing at 60O C for 30 sec. PCR was 
performed at 35 cycles with final extension at 70O C for 10 min. The PCR product was 
run into 1% agarose gel at 90V for 80 min.  The gel was photographed using Fotodyne 
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software. The PCR products were eluted from the gel using QIAquick Gel Extraction Kit 
(Qiagen) and sent out for DNA sequencing at KSU-DNA sequencing facility, 
Department of Plant Pathology, Kansas State University for the confirmation of correct 
amplification of PCR products. 
 2.2.7. Immunohistochemical study 
 
               Immunohistochemistry was performed by Dr. Gunjan Gakhar at Dr. T. A 
.Nguyen’s lab. Immunohistochemsitry was performed on paraffin-embedded human 
breast tumor tissue (Histologic type: Infiltrating ductal carcinoma; Histologic grade: 
Nottingham Grade 3; Tumor type: PT2, PN0, PMO with undetected lymphovascular 
invasion) by following standard protocol for 3, 3-diaminobenzidine (DAB) and using 
rabbit anti-Cx46 antibody (USBiological). In brief, human breast tissue slides were 
baked for 1 hr at 56 O C. Paraffin was washed off the tissue by rinsing three times in 
xylene for 5 min each followed by graded series of ethanol washes. Slides were washed 
with distilled water twice before incubating with antigen retrieval in a steamer for 20 min. 
Slides were incubated in 3% hydrogen peroxide and washed twice in PBS-T. Slides 
were blocked in horse serum for 1 hr and then rabbit anti-Cx46 (1:200, US biological) 
was applied for 1 hr. Slides were again washed for 15 min in PBS-T and incubated in 
secondary antibody (1:200) for 45 min. ABC Elite reagent was applied for 15 min before 
incubating with DAB. Slides were counterstained and mounted. 
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 2.2.8. Hypoxia study 
 
               Hypoxia conditions were considered as 1% O2, 5% CO2 at 37OC and 100% 
relative humidity. Hypoxia conditions were created by a Proox C21 hypoxic chamber 
(BioSpherix, Lacona, NY) using nitrogen and CO2 as displacement gases. Normoxia 
conditions were considered as 21% O2, 5% CO2 at 37°C and 100% relative humidity. 
For hypoxia studies, 6 × 105 rabbit NN1003A cells were preincubated with DMEM low 
glucose media (supplemented with 10% FBS) at 21% O2, 5% CO2 (normoxic conditions) 
for 12 hr. Following this incubation, the media was replaced with DMEM low glucose 
complete media that was pre-equilibrated to 1% O2. Then the cells were incubated 
under hypoxic conditions (1% O2, 5% CO2) in Proox C21 hypoxic chamber (BioSpherix) 
and harvested after 1–7 days. Whole cell lysates were run in 8% SDS-PAGE followed 
by western blot to check the expression levels of different connexins. 
 
 2.2.9. siRNA transfection 
 
               A set of four siRNAs, against Cx46, were purchased from Qiagen 
(Valencia, CA). The siRNAs and their target sequences are presented below. The 
siRNA with catalog number SI00131670 and target sequence: 5’-CGC ATG GAA GAG 
AAG AAG AAA-3’ was able to produce the most effective gene silencing effect. This 
siRNA was used in all the experiments thereafter and designated as “anti-Cx46” siRNA. 
Negative non-silencing control siRNA (a siRNA with no homology with mammalian 
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genes) was also purchased from Qiagen. HLEC (human lens epithelial cells) or MCF-7 
cells were cultured under normoxic conditions (5% CO2, 21% O2) on 60-mm dishes. 2 × 
106 HLEC or MCF-7 cells were transfected with 512 ng of Cx46 siRNA (final 
concentration 10 nM) or 512 ng negative control siRNA (10nM) and 20 μl of HiPerFect 
transfectant reagent (Qiagen). After transfection, cells were incubated under normoxic 
conditions (21% O2, 5% CO2) and harvested at different time intervals (24 hr and 48 hr 
for HLEC and 12 hr, 24 hr and 48 hr, for MCF-7 cells). Whole cell lysates were analyzed 
by western blot. 
 
SiRNA Catalog Number Target Sequence 
1 SI03094203 CTG CAC ATC GTG CGC ATG GAA 
2 
 
SI00131656 
ACC GGA GGA CTT GGC CAT CTA 
3   (Anti-Cx46 
siRNA) 
SI00131670 
 
CGC ATG GAA GAG AAG AAG AAA 
 
4 SI00131663 
 
CTG CGC GTC CCT GCT GCT CAA 
 
 
Table 2.1 The siRNAs used to knock-down Cx46 
 
 2.2.10. Cell viability assay 
 
          Cell viability assay was performed using CellTiter-Blue® Cell Viability Assay kit 
(Promega, Madison, WI). The kit applies the fluorometric detection of resorufin 
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converted from resazurin (Ahmed, Gogal et al. 1994) by viable cells. The amount of 
fluorescence measured is directly proportional to the number of viable cells. For this 
assay, 3 X 104 HLEC or MCF-7 cells, in 100 μL of DMEM low glucose media or MEM 
media respectively, were seeded into each well in 96-well microtiter plates and cultured 
for 14 hr at 37OC under normoxic conditions (21% O2, 5% CO2). The cells were then 
transfected with 10 ng (per well, final concentration 10 nM) of Cx46 siRNA or 10 ng 
negative nonsilencing siRNA along with 0.75 μL (per well) of HiPerFect transfectant 
reagent and incubated for 24 hr under normoxic conditions (21% O2, 5% CO2). Cells 
with no siRNA treatment were considered as controls. Following this incubation, the 
media for HLEC or MCF-7 cells were changed with 100 μl (per well) of their respective 
media that was equilibrated to 1% O2. Then the cells were incubated under hypoxic 
conditions (1% O2, 5% CO2) in a Proox C21 hypoxic chamber (BioSpherix, CA) for 
different time intervals depending on the cell type (6 hr, 12 hr, 18 hr and 36 hr for HLEC 
and 12 hr and 24 hr for MCF-7 cells). Another set of 96-well plates of HLEC or MCF-7 
cells with similar siRNA treatment containing 100 μl media but equilibrated to 21% O2 
were incubated under normoxic conditions (21% O2, 5% CO2) for the same interval of 
time. For the estimation of number of viable cells, 20 μL of Cell Titer-Blue reagent was 
added in each well for MCF-7 or HLEC incubated under hypoxic or normoxic conditions 
and following incubation, for 4 hr for HLEC or 3 hr for MCF-7 cells, at 37OC, 
fluorescence was recorded at 560(5)Ex/590(5)Em. 
 
               To determine the cell viability of wild-type N2A cells and N2A cells 
overexpressing Cx46-GFP or Cx43 GFP under hypoxic or normoxic conditions, 3 X 104 
81 
 
cells (per well of 96-well microtiter plate) were cultured in 100 μL DMEM low glucose 
media for 14 h at 37OC under normoxic conditions (21% O2, 5% CO2). Then the media 
was replaced with 100 μL (per well) DMEM low glucose media equilibrated to 1% O2 or 
21% O2. The cells were then incubated under hypoxic or normoxic conditions and cell 
viability was assessed every 4 hr for up to 24 hr. To measure the number of viable cells 
20 μL of Cell Titer-Blue reagent was added in each well, incubated for 4 hr at 37OC and 
fluorescence was recorded at 560(5)Ex/590(5)Em. 
 
 2.2.11. Cell fractionation 
 
               Cell fractionation was performed using Qproteome Cell Compartment Kit 
(Qiagen, CA, #37502) according to the instruction manual. In brief, 5 X 106 MCF-7 cells 
were collected by scraping and washed with ice-cold phosphate-buffer saline (PBS, 137 
mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4). Cells were 
centrifuged at 500g for 10 min and cell pellet was lysed in 1mL ice cold extraction buffer 
CE1 containing protease inhibitor solution (1:100). Then, the lysate was centrifuged at 
1000g for 10 min at 4O C and the supernatant containing cytosolic proteins fraction was 
collected. The pellet was further resuspended in 1mL ice-cold extraction buffer CE2 and 
incubated for 30 min on a shaker. Resuspended cell pellet was again centrifuged at 
6000g for 10 min and supernatant representing membrane protein fraction was 
collected. The nuclear proteins fractions was isolated by treating the cell pellet, obtained 
after above centrifugation step, with 7uL Benzonase Nuclease and extraction buffer, 
CE3, followed by centrifugation at 6800g for 10 min. The supernatant, thus obtained, 
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contained nuclear proteins. All fractions, cytosolic, membrane and nuclear proteins, 
were quantitated by Bio-Rad Protein Assay and analyzed by western blot.  
 
 
 2.2.12. Immunofluorescence study 
 
               MCF-7 cells were grown on cover-slips in a 12 well plate. When confluency 
reached to 70-80%, cells were fixed in 4% paraformaldehyde for 10 min followed by 
permeabilization with 0.05% Tritron-X100 for 30 min. Then the cells were blocked in 3% 
bovine albumin solution (BSA) for 2 hr at 4OC. After blocking, cells were incubated with 
anti-Cx46 antibody (dilution 1:200) for overnight at 4O C. Cells were washed 3 times 
with PBS buffer and incubated with secondary Alexa Fluor-568 (red color, dilution 
1:200) anti-rabbit antibody for 2 hr at room temperature. The nuclei were counterstained 
with DAPI (blue color, dilution 1:1000). The cover-slips were then washed 3 times in 
cold PBS and mounted onto slides using ProLong Gold Antifade reagent. The images 
were taken using a Leica DMI 6000 B microscope (Leica, Deerfield, IL). 
 
 2.2.13. Human breast tumor and normal tissues 
 
               The human breast tumor tissue lysates were purchased from Protein 
Biotechnologies, Ramona, CA. The characterizations of human breast tumors tissues 
are as follows: Tumor breast tissue 1: Infiltrating Ductal Carcinoma, Grade 2, Stage IIA. 
T2N0M0, source: female, 42 years. Tumor breast tissue 2: Invasive Ductal Carcinoma, 
Grade 2, Stage IIA. T2N0M0, source: female, 42 years. The human adult normal breast 
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tissue lysate was purchased from Novus Biologicals, Littleton, CO. Twenty microgram of 
total protein of each lysate was loaded and run in 8% SDS-PAGE. The blot was probed 
with rabbit polyclonal anti-Cx46 antibody  
 
 2.2.14.  Xenograft tumors of MCF-7 cells in Nu/Nu mice 
 
          Nu/Nu mice (strain NuFoxn1) were purchased from Charles River Laboratory 
(Wilmington, MA). Mice were implanted with 17 β-estradiol (1.7 mg / pellet) one week 
before the injection of 1 × 107 MCF-7 breast cancer cells subcutaneously into the 
inguinal region of mammary fat pad. Cell viability of MCF-7 cells was performed before 
the injection. Mice were observed for any change in behavior, appearance or weight. 
Two weeks after MCF-7 cell injection, tumors were injected with 7.5 μg of anti-Cx46 
siRNA or negative non-silencing siRNA or no siRNA (control) every 48 hr for minimum 
of 10 days to maximum of 18 days. Depending on the size of each tumor the siRNAs 
were injected directly at 2 or 3 different locations. The tumor size was measured in 2 
dimensions by a caliper every other day before injection. The tumor volume was 
estimated by the formula: tumor volume = a (b2)/2, where a and b are the tumor length 
and width, respectively, (Gieseg, Man et al. 2004) in mm. The tumor size measured 
before first siRNA injection is considered Day 0 measurement. After 10 days of first 
injection, 2 anti-Cx46 siRNA treated, 1 negative non-silencing siRNA treated and 1 
control (no siRNA) tumors were dissected out. The size of two anti-Cx46 siRNA treated 
tumors became almost undetectable at Day 12. Three anti-Cx46 siRNA treated tumors 
were dissected out at Day 16. The rest of the anti-Cx46 siRNA treated tumors were 
isolated from euthanized mice at Day 18. Tumors were dissected out, homogenized and 
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lysed in RIPA buffer. The lysates were sonicated for 10 sec for 3 times. Whole tumor 
tissue lysates were quantitated by Bio-Rad Protein Assay and analyzed by western blot. 
 2.2.15. Statistical analysis 
 
For statistical analysis “Origin” software (Microcal Software Inc., Northampton, 
MA) was used. The level of significance (see “*” in figure legends) was considered at p 
< 0.01 or p < 0.001 using paired t test analyses. All data are presented as mean ± 
s.e.m. of at least 3 independent experiments. 
                                                      
2.3. Results 
 2.3.1. The effect of hypoxia on connexin isoforms present in lens 
 
               The Cx46 is highly expressed in the fiber cell region which is located at the 
hypoxic center of the lens. Therefore, I first determined the effect of low oxygen on 
different connexin isoforms expressed in lens cells. For this purpose, rabbit lens 
epithelial NN1003A cells were incubated under hypoxic conditions (1% O2, 5% CO2) as 
well as under normoxic conditions (21% O2, 5% CO2). We found that the Cx46 protein 
level was elevated during 4–7 days of hypoxia in rabbit NN1003A lens epithelial cells 
(Figure 2.3). Interestingly, increase in Cx46 protein was concomitant with decrease in 
Cx43 protein level during 4-7 days of low oxygen treatment, whereas, Cx50 protein level 
was unchanged (Figure 2.3). However, normoxia treatment (21% O2, 5% CO2) had no 
effect on expression level of any of the connexins. 
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Figure 2.3 The upregulation of Cx46 protein in response to 1% O2 (hypoxia) in 
rabbit lens epithelial NN 1003A cells.  
Cells were subjected to hypoxia or normoxia and harvested at 0–7 days. Connexin 
protein levels were analyzed by western blot using antibody against Cx46, Cx43 and 
Cx50. Tubulin blot acted as a loading control.  
 
 2.3.2. Cx46 protects human lens epithelial cells from hypoxia-induced 
death 
 
               As Cx46 protein was increased under hypoxia, I speculated whether lens 
epithelial cells are hypoxia-resistant due to the Cx46 protein. I downregulated Cx46 
protein in human lens epithelial cells (HLEC) using selective siRNA (Figure 2.4) and 
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investigated the effect of Cx46 downregulation on cell viability under hypoxic conditions 
(1% O2, 5% CO2). A set of four siRNAs (see Methods and Materials for details) was 
used separately to knock down Cx46 with the purpose of identifying the most potent 
siRNA for using in subsequent experiments (Figure 2.4A). As seen in the figure, the 
siRNA 3 (or anti-Cx46 siRNA) was able to produce maximum Cx46 protein knockdown 
as determined by western blot (Figure 2.4A). HLEC, treated with the anti-Cx46 siRNA, 
showed about 85% selective knockdown of Cx46 protein expression after 24 hr and 48 
hr of transfection (Figure 2.4B and D). The action of the anti-Cx46 siRNA was specific 
as it did not result in knocking down another connexin, Cx50, which shares considerable 
sequence similarity with Cx46. Cells transfected with negative non-silencing siRNA 
(negative control) showed no alteration in Cx46 protein level (Figure 2.4C). 
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Figure 2.4 siRNA knockdown of Cx46 in HLEC.  
(A) Western blot analyses of Cx46 protein in HLEC (2 × 106) control (untransfected) or 
transfected with 512 ng siRNA 1,siRNA 2, siRNA 3 and siRNA 4 (final concentration 10 
nM) for 24 hr. siRNA 3 or anti-Cx46 siRNA showed maximum knockdown of Cx46 
protein. (B) Western blot analyses of Cx46 and Cx50 protein in HLEC (2 × 106) 
transfected with 512 ng anti-Cx46 siRNA (final concentration 10 nM) or (C) 512 ng 
negative nonsilencing siRNA for 0-72 hr. Cx50 blot was done to show specific action of 
the siRNA. (D) Densitometric analyses showed effective knockdown (more than 85%) of 
Cx46 was achieved using anti-Cx46 siRNA. Cx46 and tubulin (control) bands were 
digitized using UN-SCAN-It software. The average pixel value for each Cx46 band was 
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normalized against average pixel value for corresponding tubulin band and plotted in % 
of control. 
  
                Next, I analyzed the effect of Cx46 knockdown on HLEC viability under 
hypoxic conditions (1% O2, 5% CO2). HLEC, with Cx46 knocked-down, showed 
significant reduction in cell viability under hypoxia (Figure 2.5A). Anti-Cx46 siRNA 
treated HLEC viability was reduced to 23% at 6 hr, 38% at 12 hr and 42% at 18 hr 
compared with untreated (control) or non-silencing siRNA treated cells (Figure 2.5A) 
under low oxygen. Interestingly, Cx46 downregulation had no effect on HLEC viability 
under normoxic conditions (Figure 2.4B) which suggested that Cx46 provides 
protections to lens cells only against hypoxia-induced death. 
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Figure 2.5 Cx46 downregulated human lens epithelial cells (HLEC) are susceptible 
to hypoxia induced death.  
A total of 3 × 104 HLEC (per well of 96-well microtiter plate) were treated with 10 ng (per 
well, final concentration 10 nM) of anti-Cx46 siRNA or non-silencing siRNA (10 nM) or 
no siRNA (control) and preincubated for 24 hr under normoxic conditions (21% O2, 5% 
CO2). Following that the cells were incubated under hypoxia (A) or normoxia (B) and 
cell viability was measured by fluorometric resazurin reduction method at 6, 12, 18 and 
36 hr intervals. Data are represented as mean ± s.e.m of 3 independent experiments. 
Asterisk indicates significant statistical difference (p < 0.01) between indicated data and 
controls (cell viability at 12, 18 and 36 hr for no-siRNA or negative control siRNA 
treatment). 
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 2.3.3. Overexpression of Cx46 increases the cell viability of hypoxia-
susceptible neuronal N2A cells in hypoxic conditions 
 
To further establish the role of connexin46, Cx46 and Cx43 were stably 
overexpressed as a GFP tagged fusion protein in hypoxia-sensitive murine neuronal 
N2A cells and cell viability was assessed under hypoxic conditions. N2A cells are gap 
junction deficient. They do not express endogenous Cx46 or Cx43 proteins (Figure 
2.6A). N2A cells transfected with Cx43-GFP or Cx46-GFP expressed fusion proteins at 
predicted molecular weight of ∼71 kDa and 73 kDa, respectively (Figure 2.6B) as 
determined by western blot using anti-GFP antibody. These N2A cells overexpressing 
Cx46-GFP or Cx43-GFP were incubated under hypoxic conditions (1% O2, 5% CO2) or 
normoxic conditions (21% O2, 5% CO2) and cell viability was assessed by fluorometric 
resazurin reduction method. Wild-type N2A cells were hypoxia sensitive as they began 
to die after 4 hr under hypoxic conditions and cell viability was reduced by 40% at 12 hr 
and almost by 90% at 24 hr (Figure 2.7A). The cell viability of N2A cells overexpressing 
Cx43-GFP showed the same pattern as wild-type N2A cells with cell viability reducing 
significantly during 4–24 hr time period at 1% O2 (Figure 2.7A). But interestingly, N2A 
cells overexpressing Cx46-GFP remained viable to a considerable extent even after 12 
hr at 1% O2. The cell viability of these cells was only reduced by 3% at 12 hr and 51% 
at 24 hr at 1% O2. No reduction in cell viability was observed for wild type, Cx46-GFP or 
Cx43-GFP stably transfected cells under normoxic conditions (Figure 2.7B). Taken 
together, the results suggested that Cx46 can confer protection to a hypoxia sensitive 
cell while another connexin, Cx43, cannot. 
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Figure 2.6 The endogenous and exogenous expression of Cx46 and Cx43 
proteins in N2A cells  
(A) Western blot analyses of Cx46 and Cx43 in N2A cells. 20 μg of total protein was 
loaded in each lane. Rabbit lens epithelial NN1003A cell lysate was also loaded as 
positive control for anti-Cx46 and anti-Cx43 antibodies. (B) Western blot analyses of 
stable overexpression of Cx46-GFP and Cx43-GFP proteins in neuronal N2A cells. The 
blot was probed with antibody against GFP. Stably transfected N2A cells 
overexpressing Cx46-GFP or Cx43-GFP were generated by transfecting cells with 
plasmid encoding Cx46-GFP or Cx43-GFP and then growing the cells for 6 weeks in the 
presence of G418 antibiotic.  
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Figure 2.7 Overexpression of Cx46 in hypoxia sensitive neuronal N2A cells 
confers survival in hypoxia (1% O2).  
A total of 3 × 104 wild-type N2A cells or N2A cells, stably overexpressing Cx46 or Cx43, 
were incubated under (A) hypoxic conditions (1% O2, 5% CO2) and (B) normoxic 
conditions (21% O2, 5% CO2). The viability was assessed every 4 hr for up to 24 hr by 
fluorometric resazurin reduction assay. The data are plotted as mean ± s.e.m of three 
independent experiments. Asterisk indicates the statistical significance (p < 0.01) 
between indicated data and control (N2A-WT). 
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 2.3.4. Cx46 expression in breast cancer cells and breast tumor tissues 
 
               Tissues, other than lens, reported to express Cx46 protein are lung adenoma 
and lung alveolar cells (Abraham, Chou et al. 1999; Avanzo, Mesnil et al. 2006), 
Schwann cells(Chandross 1998) and bone osteoblastic cells (Koval, Harley et al. 
1997). Here I showed, for the first time, that human breast cancer cells and human 
breast tumor tissues express Cx46 protein. Expression of Cx46 protein was detected in 
MCF-7 human breast adenocarcinoma cells as determined by western blot analyses; 
however, in normal human mammary epithelial cells (HMEC) the expression was not 
seen (Figure 2.8A). In contrast, Cx43 protein was strongly expressed in HMEC and 
weakly expressed in MCF-7 cells. The expression of Cx46 was further confirmed by RT-
PCR which showed the presence of Cx46 mRNA in MCF-7 cells but not in HMEC 
(Figure 2.8B). Next, I investigated the expression of Cx46 protein in human breast 
tumor tissue. Indeed, Cx46 protein was present in premetastatic breast tumor as 
determined by immunohistochemistry (Figure 2.8C). In addition, immunoblot analyses 
showed that the Cx46 protein was highly expressed in human tumor tissues as 
compared with normal breast tissue (Figure 2.8D). 
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Figure 2.8 Cx46 is expressed in human breast cancer cells and human breast 
tumors. 
 Breast cancer cell MCF-7 express Cx46 protein as determined by western blot (A) and 
RT-PCR study (B). HMEC, Human mammary epithelial cells. (C) Immunohistochemistry 
showing the expression of Cx46 protein in premetastatic breast tumors. The blue arrow 
indicates Cx46 staining. The characterization of this tumor breast tissue is infiltrating 
ductal carcinoma, Grade 3, T2NOMO. (D) western blot analyses showing Cx46 protein 
is upregulated in premetastatic breast tumor tissue. Tumor breast tissue 1: Infiltrating 
Ductal Carcinoma, Grade 2, Stage IIA. T2N0M0, source: female, 42 years; Tumor 
breast tissue 2: Invasive Ductal Carcinoma, Grade 2, Stage IIA. T2N0M0, source: 
female, 54 years. [The experiments that generated (A), (B) and (C) of this figure were 
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carried out at Dr. T. A. Nguyen’s lab in Department of Diagnostic 
Medicine/Pathobiology, Kansas State University.] 
  
 
                I also determined the subcellular localization of Cx46 protein in MCF-7 cells. 
Immunofluorescence study with Cx46 antibody showed staining mostly at the 
cytoplasmic region (perinuclear region) (Figure 2.9A). The presence of Cx46 gap 
junction plaques at the cell-cell interfaces was not detected (Figure 2.9A). To confirm 
this, I performed subcellular fractionation of MCF-7 cells to isolate cytosolic, membrane 
and nuclear proteins. These fractions were then analyzed by western blot using anti-
Cx46 antibody that showed the presence of majority of Cx46 protein in the cytosolic 
fraction (Figure 2.9B). The membrane fraction also showed the presence of Cx46 
immunoreactive band. Since the membrane fraction contained plasma membrane and 
endoplasmic reticulum (ER) membrane proteins (Figure 2.9B), therefore, the presence 
of Cx46 at plasma membrane could not be ruled out. 
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Figure 2.9 Localization of Cx46 protein in MCF-7 cells.  
(A) Immunofluorescence analysis of MCF-7 cells stained with anti-Cx46 antibody (red) 
and nuclear stain DAPI (blue).  
(B) Western blot analyses of Cx46 protein of different subcellular compartments of 
MCF-7 cells. Cells were fractionated into cytosolic, membrane and nuclear 
compartments using Qproteome Cell Compartment Kit. Equal amounts of total protein, 
from each fraction, were subjected to SDS-PAGE followed by western blots. The blots 
were also probed with antibodies against a plasma membrane marker protein (Na+-K+ 
ATPase), endoplasmic reticulum marker protein (Calnexin), cytosolic marker (GAPDH), 
and nuclear marker (Lamin) to show that proper fractionation was achieved. 
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 2.3.5. Downregulation of Cx46 in MCF-7 cells increases hypoxia-induced 
cell death 
 
               The presence of Cx46 in MCF-7 cells and absence in HMEC led us to 
hypothesize that breast cancer cells and breast tumors also use Cx46, as an adaptation 
to hypoxia, to survive and grow. To confirm this, Cx46 protein was downregulated in 
MCF-7 cells using anti-Cx46 siRNA (Figure 2.10A) to more than 60% and 80% (Figure 
2.10B) after 24 hr and 48 hr of transfection, respectively. Downregulation of Cx46 
remarkably reduced the MCF-7 cell viability to approximately 34% at 12 hr and 40% at 
24 hr under hypoxic conditions (1% O2, 5% CO2) as compared with control (no siRNA) 
or negative non-silencing siRNA treated cells (Figure 2.11). As also seen in the case for 
HLEC, the downregulation of Cx46 had no effect on MCF-7 cell viability under normoxia 
(Figure 2.11). These data clearly demonstrated that human breast cancer cells, MCF-7, 
also utilize Cx46 to survive against death caused by hypoxia. 
 
98 
 
 
 
Figure 2.10 siRNA mediated downregulation of Cx46 in MCF-7 cells.  
(A) A total of 2 × 106 MCF-7 cells were transfected with 512 ng anti-Cx46 siRNA (final 
concentration 10 nM) or negative non-silencing siRNA (10nM). Level of knockdown was 
determined by western blots using anti-Cx46 antibody at 12, 24 and 48 hr after 
transfection. The same blots were probed with anti-tubulin antibody to show equal 
loading of protein in each lane. Cx26 blot was done to show the absence of any 
nonspecific action of anti-Cx46 siRNA in MCF-7 cells for another connexin protein. (B) 
Densitometric analyses shows maximum knockdown was achieved between 24 and 48 
hr time period.  
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Figure 2.11 Downregulation of Cx46 in MCF-7 cells decreases cell viability under 
hypoxic conditions. 
 3 × 104 MCF-7 cells (per well of 96 well microtiter plate) were preincubated with 10 ng 
(per well, final concentration 10 nM) negative non-silencing siRNA or anti-Cx46 siRNA 
for 24 hr at normoxic conditions (21% O2, 5% CO2) and then cells were kept at hypoxic 
conditions (1% O2, 5% CO2) or normoxia. Cell viability was assessed at 12 hr and 24 hr. 
The data are represented as mean ± s.e.m of three independent experiments. The 
asterisk indicates significant statistical difference (p < 0.01) between indicated data and 
controls (cell viability at 12 and 24 hr for no-siRNA or negative control siRNA treatment). 
 
 
 
100 
 
 2.3.6. Downregulation of Cx46 inhibits the growth of MCF-7 tumor 
xenografts in nude mice 
 
                To further investigate the function of Cx46 as a hypoxia survival factor, I 
carried forward our work to an in vivo human tumor-bearing xenograft nude mouse 
system. I asked whether Cx46 plays a similar and significant hypoxia-protective role in 
the growth of human breast tumors in vivo. Estrogen stimulated immunodeficient Nu/Nu 
mice were injected with 1 × 107 MCF-7 cells into the inguinal region of mammary fat pad 
to develop tumor of human origin. Two weeks after MCF-7 cells injection, newly formed 
tumors were directly injected with 7.5 μg of anti-Cx46 siRNA (n = 10 tumors) or negative 
non-silencing siRNA (n = 7 tumors) or no siRNA (control, n = 7 tumors) every 48 hr for a 
minimum of 10 to maximum of 18 days. Tumor size was measured every alternate day 
before siRNA injection and hence the tumor size measured before first injection was 
considered as Day 0 (measurement). I found that after 10 days of siRNA injection (total 
of 5 siRNA injections with injection every 48 hr), all the tumors with no siRNA (n = 7 
tumors) or nonsilencing (n = 6 tumors) siRNA treatment increased in size with time, with 
an average increase of about 426% and 482%, respectively, when compared to Day 0 
(before first injection; Figure 2.12). No notable reduction in size of control (no siRNA) or 
nonsilencing siRNA injected tumors was observed even after 18 days (Table 2.2 and 
2.4). However, anti-Cx46 siRNA treatment inhibited the tumor growth significantly with 
average increase of only about 30% (compared to Day 0) after 10 days of injection 
(Figure 2.12-2.14). Any noteworthy increase in the size of anti-Cx46 siRNA treated 
tumors was not noticed from Day 10 to Day 18 (Table 2.3). 
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Figure 2.12 siRNA mediated downregulation of Cx46 in mouse tumor xenografts 
inhibits the growth of breast cancer tumors in vivo.  
Mice were implanted with 17ß-estradiol (1.7 mg/pellet) followed by the injection of 1 × 
107 MCF-7 cells subcutaneously into the inguinal region of mammary fat pads to 
develop breast tumors. After 2 weeks, animals were injected with 7.5 μg Cx46 siRNA 
(n = 10 tumor) or 7.5 μg negative control siRNA (n = 7 tumors) every 48 hr for 10 days. 
The siRNAs were injected directly at 2–3 different locations of each tumor. Animals with 
no siRNA treatment represent control (n = 6 tumor). The tumors size was measured in 
two dimensions by a caliper every alternate day before injection. The results after 10 
days (total 5 injections) show a significant decrease in tumor growth of anti-Cx46 siRNA 
treated mice. Data are plotted as mean ± s.e.m of two different independent 
experiments. Asterisk indicates statistical difference (p < 0.001) between anti-Cx46 
siRNA treated tumors and control (no siRNA) tumors.  
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Figure 2.13 The images of control (no treatment), anti-Cx46 siRNA and negative 
control siRNA treated MCF-7 tumor-bearing xenograft mice at Day 0 and Day 10.  
The reduction of tumor size at Day 10 is observed only after anti-Cx46 siRNA treatment.  
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Figure 2.14 The gross images of control (no siRNA), or nonsilencing siRNA 
treated (negative control) or anti-Cx46 siRNA treated xenograft tumors in Nu/Nu 
mice.  
Mice were euthanized and tumors were isolated after 10 days of siRNA treatment. The 
images were taken by Dr. T. A. Nguyen from Department of Diagnostic 
Medicine/Pathobiology, Kansas State University. 
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Table 2.2 The volume (mm3) of no siRNA injected (control) tumors measured 
every alternate day. E = Euthanized. 
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Table 2.3 The volume (mm3) of anti-Cx46 siRNA injected tumors measured every 
alternate day.  
The anti-Cx46 siRNA was injected directly into the MCF-7 xenograft tumors every 48 hr 
and each tumor size was measured prior to siRNA injection. Hence the tumor size 
measured prior to first injection was considered as day 0 (measurement). Tumor 14 and 
tumor 15 appeared at Day 6 and hence Day 6 was considered as Day 0 for these two 
tumors. E = Euthanized.  
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Table 2.4 The volume (mm3) of negative non-silencing siRNA injected tumors 
measured every alternate day.  
The non-silencing siRNA was injected directly into the MCF-7 xenograft tumors every 
48 hr and each tumor size was measured prior to siRNA injection. The tumor size 
measured prior to first injection was considered as day 0 (measurement). Tumor 23 
appeared at Day 6 and hence Day 6 was considered as Day 0 for this particular tumor. 
E = Euthanized. 
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                To confirm that the inhibition of anti-Cx46 siRNA treated tumor growth is due 
to Cx46 downregulation, I analyzed the tumors by western blot. Effective knockdown of 
Cx46 protein was only seen in tumors injected with anti-Cx46 siRNA (Figure 2.15). Of 
the ten anti-Cx46 siRNA injected tumors, six tumors (tumors 16 and 17 at Day 10; tumor 
10 at Day 16; tumors 11, 14 and 15 at Day 18) presented reduced level of Cx46 protein 
(Figure 2.15), two tumors (tumors 8 and 13 at Day 16) showed no reduction in Cx46 
protein expression (Figure 2.15 B) and two tumors (tumors 9 and 12, Table 2.3) became 
too small to be analyzed by western blot. We also measured Cx26 protein level in all 
tumors to investigate any nonspecific effect of the siRNA but no change in Cx26 protein 
level was observed. This suggested that the decreased tumor growth in xenograft mice 
resulted due to selective knockdown of Cx46 by anti-Cx46 siRNA. 
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Figure 2.15 Western blot analyses show knockdown of Cx46 in xenograft tumors 
by anti-Cx46 siRNA.  
The tumors were dissected out at (A) Day 10, (B) Day 16 or (C) Day 18. Tumors were 
harvested and Western blots were performed on whole tissue lysates using rabbit anti-
Cx46 antibody. The same blots were reprobed with anti-Cx26 antibody to show the 
specificity of anti-Cx46 siRNA action in vivo. 
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 2.4. Discussion 
 
               In the present study, I demonstrated that Cx46 helps cells to survive under 
hypoxia. Several studies have shown that the oxygen concentration inside the lens and 
in breast tumor, at early stage, can go as low as 1% (McNulty, Wang et al. 2004; 
Holekamp, Shui et al. 2005; Holekamp, Shui et al. 2006; Shui, Fu et al. 2006). 
Therefore, I chose 1% O2 for hypoxia treatment. I observed an upregulation of Cx46 
protein in HLEC under hypoxic conditions at 4–7 days but no change in protein 
expression was found under normoxia treatment (Figure 2.3). HLEC are naturally 
hypoxic cells as they survive for weeks at 1% O2. But when Cx46 was downregulated 
(by siRNA), the HLEC viability reduced significantly even after 12 hr under hypoxia 
(Figure 2.4-2.5). This indicates that lens epithelial cells survive under hypoxia by 
utilizing Cx46 protein function.  
 
               If HLEC are able to survive in hypoxia because of Cx46 protein, then 
overexpression of Cx46 should confer resistance to a hypoxia susceptible cell that lacks 
endogenous Cx46. Indeed, I observed that overexpression of Cx46 in hypoxia 
susceptible murine neuronal N2A cells significantly increased the cell viability under 
hypoxic conditions (Figure 2.7A). However, no such effect on N2A cell survival at 1% O2 
was observed when another connexin, Cx43, was overexpressed. This suggests that 
Cx46 can also help cells other than in lens to survive in hypoxic condition and this effect 
is specific to Cx46 as Cx43 overexpression did not show similar effect. 
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               To date, the gap junction connexins, Cx26, Cx32 and low level of Cx43 have 
been detected in breast cancer MCF-7 cells. Here, for the first time, I show that human 
breast cancer cells and human breast tumors also express Cx46 (Figure 2.8). Both 
Cx46 mRNA and protein were detected in breast cancer MCF-7 cells but not in normal 
HMEC (Figure 2.8A and 2.8B). Moreover, higher expression of Cx46 protein was 
observed in human breast tumor tissues than in normal breast tissues (Figure 2.8D) 
raising the possibility that Cx46 may be used as a marker in breast oncogenesis. 
Immunofluorescence staining with anti-Cx46 antibody showed that Cx46 predominantly 
localized to the cytoplasmic compartment at perinuclear region of the MCF-7 cells 
(Figure 2.9A). This observation was further confirmed by cell fractionation-western blot 
analyses that showed the presence of higher intensity Cx46 protein band in cytosolic 
fraction (Figure 2.9B). However localization of Cx46 in the plasma membrane could not 
be ruled out as membrane fraction, that contained both plasma membrane and ER 
membrane proteins, also showed Cx46 band. 
 
               Our results clearly demonstrated that Cx46 functions to protect MCF-7 cells 
against hypoxia-induced death. MCF-7 cells with downregulated Cx46 protein showed 
significant decrease in cell viability at 1% O2 (Figure 2.11). However, downregulation of 
Cx46 had no effect on cell viability under normoxia treatment (Figure 2.11). Like in 
HLEC, Cx46 may be involved only in hypoxia-signaling pathways in breast cancer cells. 
The function of Cx46 in human breast tumor formation was investigated, in vivo, in 
human tumor xenograft-bearing nude mice. The tumor of human origin in nude mice 
was generated by injecting MCF-7 cells into inguinal region of mammary fat pads. As 
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levels of Cx46 protein were reduced maximally after 48 hr of anti-Cx46 siRNA 
transfection in MCF-7 cells in vitro, I injected anti-Cx46 siRNA directly into the MCF-7 
xenograft tumors every 48 hr. Consistent with the result of decreased cell viability of 
MCF-7 cells in vitro under hypoxia, dramatic inhibition of tumor growth was also 
observed in MCF-7 xenograft tumors (Figure 2.12), in vivo, treated with anti-Cx46 
siRNA even for 18 days. Thus Cx46 appeared to play a significant role in early breast 
tumor development. 
 
               I achieved significant knockdown of Cx46 protein in vivo by injecting siRNA 
directly into the xenograft tumors in nude mice. The anti-Cx46 siRNA treated xenograft 
tumors that were associated with reduced tumor growth (tumors 10, 11, 14, 15, 16 and 
17) presented low levels of Cx46 protein (Figure 2.15). Two anti-Cx46 siRNA treated 
tumors (tumors 8 and 13) manifested increased tumor growth and showed no significant 
reduction in Cx46 protein level. The relationship of Cx46 knock down level with tumor 
size clearly suggests that downregulation of Cx46 protein accounted for the reduced 
growth of xenograft tumors. 
 
               The breast cancer tumor progression is generally believed to be associated 
with loss of gap junctional intercellular communication (GJIC). The decreased 
communication of tumor cells with neighboring normal cells due to defective intercellular 
gap junctions has been shown to be beneficial for tumor progression. Therefore, the 
other gap junction connexins, Cx43, Cx26 and Cx32, expressed in breast tissue, are 
generally deemed tumor suppressors. Loss of Cx43 is correlated with breast tumor 
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progression and restoration of Cx43 protein level promoted controlled growth and less 
proliferation of cancer cells (Hirschi, Xu et al. 1996; Laird, Fistouris et al. 1999; Qin, 
Shao et al. 2002). In contrast, our studies identify a unique gap junction protein, Cx46, 
which is upregulated and acts as a proto-oncogene in early breast cancer tumors 
 
               Due to its observed cytoplasmic localization, Cx46 possibly helps breast tumor 
to adapt and survive in the hypoxic environment by mechanisms other than GJIC. 
Though, in most cases, functions of connexin proteins have been shown to be through 
their ability to form channels; evidence of connexin activity regardless of gap junction 
communication is increasing. In breast cancer MDA-MB-435 cells, Cx26 prevents 
tumorigenesis by a communication independent mechanism (Kalra, Shao et al. 2006). 
When a GJIC-incompetent variant of Cx26 was overexpressed in MDA-MB-435 cells, 
the cell proliferation and anchorage-independent growth was reduced. In addition, this 
communication defective Cx26 variant was also able to inhibit cell migration and 
invasion by decreasing the level of β1 integrin and reducing the activity of matrix 
metalloproteinase-9 (MMP-9) while increasing the tissue inhibitors of MMP-1 (TIMP-1) 
activity. Another study, done by Conklin et al (Conklin, Bechberger et al. 2007)), also 
reported that an anticancer drug, genistein, upregulates Cx43 and inhibits MDA-MB-231 
cell proliferation independent of GJIC.  
 
               The mechanism of Cx46 action needs further investigation. It seems plausible 
that Cx46 mediates its action by putative binding partners that function in the hypoxia-
survival mechanisms. It is well established that connexins interact with several kinases 
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such as protein kinase A (PKA), protein kinase C (PKC), mitogen activated protein 
kinase (MAPK) and src kinase. Cx46 shares a significant sequence homology with 
Cx43 with the C-terminal region being unique. Cx46 has a 191 amino acid long C-
terminal end, exposed to the cytoplasm, that has conserved phosphorylation and 
binding sites for PKC, CK-1 (the casein kinase-1), AKT kinase and MAPK. A recent 
study in our lab shows that C-terminal deletion mutant of Cx46 is unable to protect N2A 
cells against hypoxic cell death (Takemoto Lab, unpublished data). This indicates that 
C-terminal tail region of Cx46 is required for its hypoxia protective function. Further 
studies with mutant Cx46 proteins that are defective in phosphorylation or binding of the 
above mentioned proteins are currently underway to shed some insight, in the future, 
into how Cx46 protects cells from hypoxia.  
 
               I also speculate that another possible way Cx46 favors tumor growth is by 
inducing Cx43 protein degradation in breast tumors. It is well-established that Cx43 is 
downregulated in breast tumor and, when overexpressed, has a tumor suppressive role. 
In contrast to Cx43 expression, I found Cx46 to be highly expressed in breast tumor 
tissues when compared with the normal breast tissue. In addition, I have also found 
that, in response to hypoxia, Cx46 protein expression is strongly increased with 
concomitant reduction of Cx43 protein levels in HLEC. Further support for this 
speculation comes from another related study, in our lab; on retinoblastoma xenograft 
tumors that showed that the downregulation of Cx46 (by siRNA) was associated with 
inhibition of tumor growth and interestingly, an increase in Cx43 protein levels. How 
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Cx46 upregulation causes the degradation of Cx43 has been presented in Chapter 3 of 
the thesis. 
 
               Our data also provide evidence that the presence of Cx46 and its function as a 
hypoxia-critical-factor can be targeted for the treatment of breast cancer. This is the first 
report to utilize a natural hypoxic tissue (lens) to understand the complexity of an 
adaptive hypoxic tissue such as solid tumor for their survival strategies involving a novel 
gap junction protein. Our findings also revealed that the local administration of siRNA 
can mediate effective knock down of this target protein with minimal nonspecific effects 
and prevent tumor formation. These results will have a high impact on breast cancer 
therapeutics in designing an entirely new line of drugs to control and potentially 
eliminate early breast cancers while at the early hypoxic stage. 
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connexin46 protein to protect breast tumors from hypoxia, by Banerjee et al 2010, with 
kind permission from the journal, “International Journal of Cancer”. 
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CHAPTER 3 - Overexpression of connexin46 causes 
connexin43 degradation by ubiquitin-proteasome 
dependent pathway in rabbit lens epithelial NN1003A cells. 
 3.1. Introduction 
 
                Gap junctions are intercellular membrane channels that maintain direct 
intercellular communication through the exchange of ions, small molecules and cellular 
metabolites between neighboring cells (Goodenough, Goliger et al. 1996; Harris 2001; 
Goldberg, Valiunas et al. 2004). Gap junction channels are formed at the basolateral 
surfaces of two cells and directly connect their cytoplasms (Saez, Berthoud et al. 2003). 
Gap junction channels are composed of a transmembrane family of proteins called 
connexins (Laird 1996; Laird 2006). So far, there are 21 connexin isoforms that have 
been identified in human (Laird 2006). Gap junction mediated intercellular 
communications are involved in the regulation of important cellular processes including 
cellular homeostasis, cell growth and differentiation, morphogenesis and cell death 
(Loewenstein 1979). Loss of gap junctions has been found to be associated with 
malignant transformation (Loewenstein 1979; Trosko and Ruch 1998). 
 
                Connexins have rapid turnover rates with very short half-lives ranging from 
1.5-4 hr in the different cell types studied (Fallon and Goodenough 1981; Traub, Look et 
al. 1989; Crow, Beyer et al. 1990; Laird, Puranam et al. 1991). This short half-life of 
connexin is very unusual for integral membrane protein whose half-lives are expected to 
be long (>20h) (Herve, Derangeon et al. 2007).The reason for the rapid turnover rate is 
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not well documented, however it is assumed that connexins are continuously degraded 
and synthesized to increase or decrease the gap junctional intercellular communication 
(GJIC) as per cell’s physiological requirement. Connexins can respond to several 
extrinsic and intrinsic factors such as trans-junctional voltage, pH, carcinogenic 
chemicals and phosphorylation to control gap junctional intercellular communication 
(GJIC) (Bennett and Verselis 1992; Wang, Lee et al. 2001; Bukauskas and Verselis 
2004). Among the connexin family members, connexin43 (Cx43) is most widely 
expressed and has been shown to regulate gap junction permeability, assembly and 
disassembly by phosphorylation at its C-terminal cytoplasmic tail (Solan and Lampe 
2009). 
 
               The degradation of connexin can occur by both lysosomal and proteasomal 
pathways (Larsen and Hai 1978; Laing and Beyer 1995; Laing, Tadros et al. 1997; 
Lampe and Lau 2000; Musil, Le et al. 2000; Qin, Shao et al. 2003). Lysosomal 
pathways have been implicated to be involved in the degradation of internalized gap 
junctions. However, the proteasomal pathway for connexin degradation is not well 
characterized. In general, degradation via the proteasome involves, at first, polyubiquitin 
conjugation of target protein by the sequential action of three classes of enzymes, 
ubiquitin-activating enzyme (E1), ubiquitin conjugating enzyme (E2) and ubiquitin ligase 
(E3). Next, the ubiquitin-conjugated substrate protein is recognized and degraded by 
multisubunit protease complex 26S proteasome (Hershko and Ciechanover 1992; 
Ciechanover 1998; Lecker, Goldberg et al. 2006). There is increasing evidence that the 
ubiquitin-proteasomal pathway plays distinct roles in the turnover of connexins. Several 
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studies have shown that treatment with proteasomal inhibitors results in increases in 
Cx43 protein levels in several cell lines (Laing and Beyer 1995; Laing, Tadros et al. 
1997; Qin, Shao et al. 2003). Proteasome is also required for the endoplasmic 
reticulum–associated degradation (ERAD) of misfolded connexins during synthesis 
(VanSlyke, Deschenes et al. 2000; VanSlyke and Musil 2002). The proteasome is also 
believed to play a role in the process of internalization of Cx43 from plasma membrane 
(Leithe and Rivedal 2004). 
 
               As discussed in Chapter 1, vertebrate lens is a transparent organ consisting of 
three perceivable zones of cells, an outer layer of epithelial cells at the anterior surface, 
an intermediate layer of differentiating fiber cells (DF), and a core of closely-packed 
mature fiber cells (MF). Outer epithelial cells are differentiated to form inner fiber cells in 
the lens differentiation process that is accompanied with a loss of organelles and 
induction of crystallin proteins in the fiber cell cytoplasm (Donaldson, Kistler et al. 2001; 
Bassnett 2002; Wang, Garcia et al. 2004). Ocular lens endogenously expresses three 
connexin isoforms Cx43 (α1), Cx50 (α8), and Cx46 (α3) (Donaldson, Kistler et al. 2001; 
Berthoud and Beyer 2009). These three connexins play a major role in the proper lens 
development and differentiation. The connexins show differential spatial distribution 
within the lens. The lens epithelium primarily contains Cx43 and Cx50 (Musil, Beyer et 
al. 1990; TenBroek, Johnson et al. 1994; Dahm, van Marle et al. 1999; Rong, Wang et 
al. 2002), whereas differentiating and mature fiber cells abundantly express Cx46 and 
Cx50 (Paul, Ebihara et al. 1991; White, Bruzzone et al. 1992). During lens epithelial-to-
fiber cell differentiation Cx43 is substantially downregulated and Cx46 is significantly 
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upregulated. This change in connexin isoform expression is crucial for maintaining 
connexin mediated communications in lens. However, the underlying molecular 
mechanism of Cx46 upregulation and Cx43 downregulation during lens epithelial-to-
fiber cells transition is largely unknown.  
 
The reciprocal expression of Cx46 and Cx43 is also observed in breast 
tumorigenesis. Cx43 is widely regarded as a tumor suppressor protein. The expression 
of Cx43 is downregulated in breast tumors (Lee, Tomasetto et al. 1992; Laird, Fistouris 
et al. 1999; Shao, Wang et al. 2005), when compared to normal breast tissues, and, 
when re-expressed, Cx43 reverses the tumorigenic phenotype (Hirschi, Xu et al. 1996; 
Qin, Shao et al. 2002). In chapter 2, I have shown that, in contrast to Cx43 protein 
expression, the Cx46 is strongly expressed in breast cancer MCF-7 cells and human 
breast tumor tissues. 
 
In the present study, I demonstrated how Cx46 upregulation is associated with 
Cx43 degradation. Using an overexpression system of rabbit lens epithelial NN1003A 
cells, I find that overexpression of Cx46 causes a decrease in Cx43 protein levels. The 
Cx43 degradation, due to the overexpression of Cx46, is mediated by the ubiquitin-
proteasome pathway as determined by the observations that (i) treatment with only 
proteasome inhibitors restores the Cx43 protein level and (ii) there is an increase in 
ubiquitin conjugation of Cx43, in Cx46 overexpressing cells. I also provide evidence that 
the C-terminal tail region of Cx46 is required to induce degradation of Cx43. Thus, our 
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study shows that Cx46 has a novel function in Cx43 downregulation in addition to its 
conventional role as a gap junction protein. 
 
 3.2. Material and Methods 
 3.2.1. Antibody 
 
               Mouse anti-GFP antibody was purchased from Clontech (Mountain View, CA). 
Rabbit anti-Cx43-CT (against C-terminal) and mouse anti-β-actin antibodies were 
purchased from Sigma-Aldrich (St. Louis, MO). Anti-Cx50 antibody was purchased from 
Zymed-Invitrogen (Carlsbad, CA) and anti-ubiquitin antibody was purchased from 
Calbiochem (EMD Biosciences, OH). Mouse anti-N-terminal-Cx43 (anti-Cx43-NT) and 
mouse anti-Cx43-IF1 (used in immunofluorescence studies) antibodies were purchased 
from Fred Hutchinson Cancer Center (Seattle, WA). Rabbit polyclonal anti-Cx46 
antibody was purchased from US Biological (Swampscott, MA). 
 3.2.2. Cell culture 
 
               NN1003A rabbit lens epithelial cells were cultured in Dulbecco's modified 
Eagle's medium (DMEM, low glucose; Invitrogen, CA) supplemented with 10% fetal 
bovine serum and 50 µg/mL gentamicin, 0.05 U/mL penicillin, and 50 µg/mL 
streptomycin, pH 7.4 at 37OC in an atmosphere of 90% air and 10% CO2. All the 
experiments were done at the confluency level of 70-80% of NN1003A cells. 
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 3.2.3. Cloning and transfection 
 
               To generate NN1003A cells, stably overexpressing Cx46 or Cx50, the cDNA 
of rat Cx46 (NCBI Reference Sequence: NM_024376.1) or rat Cx50 (NCBI Reference 
Sequence: NM_153465.2) was sub-cloned into pEGFP-N3 vector (Clontech, CA) and 
transfection was carried out using LipofectamineTM 2000 (Invitrogen, CA), as described 
in chapter 2. The transfected cells were grown in the presence of 1 mg/ml G418 for 3 
weeks for the selection of positive colonies The positive colonies were then isolated and 
grown in media containing G418 (1 mg/ml) thereafter  
 
               The cDNA of rat Cx43 (NCBI Reference Sequence: NM_012567.2) was also 
sub-cloned into the pEGFP-N3 vector. To generate the Cx46 mutant protein with 
deleted C terminus tail region (Cx46-dCT, deletion in residues 232-416), the truncated 
cDNA of rat Cx46 was also sub-cloned into pEGFP-N3. The rat Cx46 cDNA was also 
sub-cloned in pQE-TriSystem vector (Qiagen, CA) to get Cx46-His (-His tagged) 
protein. These plasmids were used in transient transfection experiments. 
 
                All transient transfections were carried out at 70-80% confluency of cells and 
using LipofectamineTM 2000. The expression of Cx43-GFP, Cx46-GFP, Cx50-GFP and 
Cx46-dCT-GFP were checked by western blot analyses using anti-GFP antibody. The 
expression of Cx46-His fusion protein was verified by immunofluorescence analysis 
using anti-His antibody 
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 3.2.4. Whole cell homogenate preparations (WCH) 
 
               Cells were washed 3 times with cold phosphate-buffered saline (PBS, 137 mM 
NaCl, 2.7 mM KCl, 10 mM sodium phosphate dibasic, 2 mM potassium phosphate 
monobasic and a pH of 7.4), collected by scraping from plates and centrifuged at 4000 
rpm for 5 min at 4OC. The cell pellets were lysed in ice cold 1X RIPA buffer [10 mM Tris-
HCl (pH 7.5),150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium 
deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM 
Na3VO4, 1 µg/ml leupeptin] containing 1 mM PMSF. Cell lysates were sonicated for 10 
sec (3 times) and protein concentration of each sample was measured using Bio-Rad 
Protein Assay. 
 
 3.2.5 Reverse Transcriptase (RT)-PCR 
 
               Total RNA was isolated from NN1003A wild type cells and cells stably or 
transiently overexpressing Cx46-GFP or GFP (empty vector) using RNeasy Mini Kit 
(Qiagen, CA) and the RT-PCR was carried out using SuperScriptTM III First- Strand RT-
PCR kit (Invitrogen, CA) according to the manufacturer’s protocol. The primers for Cx43 
cDNA were 5’-GAT GAG CAG TCT GCC TTT CGT -3’ and 5’-CGT TGA CAC CAT CAG 
TTT GG-3’. The primers for β-actin were 5’-GAA ATC GTG CGT GAC ATT AAG-3’ and 
5’-CTA GAA GCA TTT GCG GTG GAC GAT GGA GGG GC-3’. For PCR, initial 
activation was done at 94OC, followed by denaturation at 94O C for 1 min, annealing at 
30O C for 1 min and extension at 72OC for 30 sec. The number of cycles for PCR was 
20 or 25. The PCR products were run in 1.2 % agarose gel. DNA bands, at expected 
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position, were eluted and sent for sequencing to confirm correct amplification of the 
PCR products. 
 3.2.6. Plasma membrane fractionation 
 
               The fractionation of plasma membrane proteins from untransfected or 
transfected NN1003A cells was carried out using QproteomeTM Plasma Membrane 
Protein (Qiagen, CA) kit according to the instruction manual. In brief, 1 X 107 cells were 
collected by a cell scraper, centrifuged and resuspended in 2 ml Lysis Buffer PM. Then 
the cells were centrifuged again at 450g for 5 min and cell pellets were resuspended in 
500 µL Lysis Buffer PM containing protease inhibitor solution (1:100). Lysis Solution PL 
(2.5 µL) was then added to the resuspended cells and, following an incubation period 
for 15 min at 4OC, cells were disrupted using a 21 gauge needle and syringe. The cell 
lysates were then centrifuged at 12000g for 20 min to remove the intact cells, cell debris 
and nuclei. The supernatants that contained cytosolic proteins, microsomes, Golgi 
vesicles and plasma membranes were incubated with 20 µL of Binding Ligand PBL, a 
ligand that is specific for the molecules on the plasma membrane, for 1 hr at 4OC. The 
ligand-plasma membrane complexes were then precipitated using Strep-Tactin 
Magnetic Beads and washed with Wash Buffer PW. The plasma membrane proteins 
were next eluted with Elution Buffer PME. The eluted fractions were quantitated by Bio-
Rad Protein Assay and analyzed by western blot. Western blot analysis was performed 
as described in Chapter 2. 
 
129 
 
 3.2.7. Immunofluorescence study 
 
               Untransfected control cells and GFP or Cx46-GFP stably overexpressing 
NN1003A cells were seeded on cover-slip in a 12 well plate. When confluency reached 
to 80%, cells were fixed in 4% paraformaldehyde, for 10 min, followed by 
permeabilization with 0.05% Tritron-X100 for 30 min. Then the cells were washed in 
PBS and blocked in 3% bovine serum albumin solution (BSA) for 2 hr at 4OC., The 
untransfected control cells were stained with rabbit anti-Cx46 antibody (dilution 1:200) 
to visualize endogenous Cx46. The cells were then treated with mouse anti-Cx43 
antibody (Cx43-IF1, dilution 1:100) for overnight at 4OC. Cells were washed 3 times with 
PBS buffer and incubated with secondary Alexa Fluor-568 (red color) anti-mouse or 
Alexa Fluor-488 (green color) anti-rabbit antibodies for 2 hr at room temperature. For 
some experiments, the nuclei were also stained with DAPI (blue color, dilution 1:1000). 
The cover-slips were then washed 3 times in cold PBS, and mounted onto slides using 
ProLong Gold Antifade reagent (Invitrogen, CA). The images were taken using a Leica 
DMI 6000 B microscope (Leica, Deerfield, IL) or a Nikon C1 scanning confocal 
microscope. The Cx46-GFP or GFP proteins were visualized under the microscopes by 
green fluorescence only (without immunostaining). 
For immunofluorescence studies involving transiently transfected cells, NN1003A 
cells were seeded on cover-slips in a 12 well plate one day before the transfection. The 
transfection was carried out using Cx46-GFP plasmid or Cx46-dCT-GFP (C-terminal tail 
deletion mutant of Cx46) and Lipofectamine 2000. The immunostaining of the cells were 
performed as described above. 
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 3.2.8. Immunoprecipitation study 
 
               Cells, stably overexpressing GFP or Cx46-GFP or Cx50-GFP and 
untransfected (control), were grown in 100 mm dishes to approximately 90% 
confluency. NN1003A cells were also transiently transfected with Cx50-GFP plasmid for 
36 hr. All the cells (untransfected, stable or transient) were harvested and total cell 
lysates were made as described previously. The total protein concentration in the whole 
cell lysates were quantified by Bio-Rad Protein Assay. To pre-clear the whole cell 
lysates, 0.25 μg of rabbit non-specific IgG and 20 μL of protein A/G-Agarose beads 
(Santa Cruz Biotechnology, CA) were added to the 750 µg of each whole cell lysate. 
The agarose beads-IgG complex was removed by centrifugation at 3,000 rpm and the 
supernatants were incubated with 5 µg of rabbit anti-Cx43CT antibody (against C-
terminal) for overnight at 4OC. After the overnight incubation, the supernatants were 
further incubated with 20 μL of protein A/G-Agarose beads for 4 h at 4OC. The beads 
were collected by centrifugation at 3,000 rpm, washed 3 times with 1X RIPA buffer (Cell 
Signaling Technology, MA) and the samples were boiled for 5 min in 2x electrophoresis 
sample buffer (Santa Cruz Biotechnology, CA). The samples were then analyzed by 
western blot with anti-ubiquitin and anti-Cx43 antibodies. For a positive control for anti-
ubiquitin antibody, a commercially available polyubiquitin chain (ubiquitin ladder, Affinity 
Research Products, UK) was used. In this chain, ubiquitin is polymerized through lysine 
48. 
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 3.2.9. Proteasome and lysosome inhibitor 
               Cells were incubated with proteasome inhibitors, ALLN (N-Acetyl-Leu-Leu-Nle-
CHO, 100µM) or MG-132 (N-[(Phenylmethoxy) carbonyl]-L-leucy l-N-[(1S)-1-formyl-3-
methylbutyl]-L-leucinamide, 10µM) or lysosome inhibitors, leupeptin (200 µM) or 
choloroquine (200 µM) for 4 hr. The cells were harvested and analyzed by western blot. 
The inhibitors were purchased from Sigma-Aldrich (St. Louis, MO). 
 3.3.10. Statistical analysis 
 
For statistical analysis “Origin” software (Microcal Software Inc., Northampton, 
MA) was used. The level of significance (see * in figure legends) was considered at p < 
0.05 using paired t test analyses. All data are presented as mean ± s.e.m. of at least 3 
independent experiments. 
 3.3. Results  
 
 3.3.1. Overexpression of Cx46 causes a decrease in Cx43 protein levels 
 
               In the ocular lens, Cx46 is mainly expressed in the fiber cell region. To 
determine the role of Cx46, we stably overexpressed Cx46 as a GFP tagged fusion 
protein in rabbit lens epithelial NN1003A cells and analyzed the effect of Cx46 
overexpression on other connexins. The cells, stably overexpressing Cx46-GFP, 
showed the expression of fusion protein as bands around 75 kDa as determined by 
western blot using antibodies against GFP (Figure 3.1A). Interestingly, stable 
overexpression of Cx46 decreased the Cx43 protein levels of both non-phosphorylated 
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(Po) and phosphorylated forms (P1 and P2). In SDS-PAGE, Cx43 usually form three 
bands depending on the phosphorylation status of the residues. The fastest migrating 
band represents nonphosphorylated form (termed as Po) and the other two slower 
migrating forms represent phosphorylated forms (termed as P1 and P2). Stable 
overexpression of Cx46 reduced the Cx43 protein levels to 50% when compared to 
untransfected or GFP transfected cells (Figure 3.2B). However Cx50 protein level was 
not changed due to the stable overexpression of Cx46 (Figure 3.2). Consistent with the 
results obtained for stably transfected cells, transient transfection of Cx46-GFP also 
showed a reduction in Cx43 protein levels at 36 hr and 48 hr after transfection. 
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Figure 3.1 Overexpression of Cx46 causes reduction in Cx43 protein levels in 
NN1003A cells.  
(A) Western blot analyses of Cx46-GFP, Cx43, Cx50 and tubulin in control 
(untransfected) cells and in cells stably overexpressing GFP or Cx46-GFP. Whole cell 
lysates were made and equal amounts of total protein were run in SDS-PAGE followed 
by immunoblot. The blot was probed with anti-GFP antibody to detect Cx46-GFP 
expression. The blots were also probed with anti-Cx43CT (against C-terminal) and anti-
Cx43NT (against N-terminal) antibodies to detect Cx43.  
(B) Densitometric analyses show significant reduction of Cx43 protein levels in Cx46-
GFP stably transfected NN1003A cells. The bands representing Cx43 and tubulin were 
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digitized by UN-SCAN-It gel software. The average pixel values were calculated for 
each Cx43 band, normalized against average pixel values for loading control (tubulin) 
and then plotted in % of control. Data are represented as mean ± s.e.m of three 
independent experiments. Asterisk indicates significant statistical difference (P<0.05) 
between indicated data and control (untransfected cells). (C) Cells were transiently 
transfected with plasmid encoding Cx46-GFP. Cell lysates were made at 0, 12, 24, 36 
and 48 hr after transfection and analyzed by western blot using antibodies against , 
GFP, Cx43 (anti-Cx43 CT), Cx50 and β-Actin.  
 
 3.3.2. Cx46 localization in NN1003A cells 
 
                Next, I determined the intercellular localization of Cx46 in the stably 
transfected cells by immunofluorescence study. Green fluorescence of Cx46-GFP 
expression was predominantly detected to an intracellular perinuclear compartment 
(Figure 3.2A). Immunofluorescence signal of Cx46-GFP localization was not observed 
at the plasma membrane region. The localization of Cx46 to the intercellular 
compartments was also detected in NN1003A cells transiently transfected with Cx46-
GFP plasmid (Figure 3.2B). 
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Figure 3.2 Localization of Cx46-GFP in stable (A) or transiently transfected 
NN1003A cells (B).  
NN1003A cells stably overexpressing Cx46-GFP were generated by transfecting cells 
with rat Cx46 cDNA cloned in pEGFP-N3 vector and then selecting cells in the presence 
of G418 antibiotic. Cells were also transiently transfected with the plasmid encoding 
Cx46-GFP for 24 hr and 48 hr. All cells were fixed with paraformaldehyde and stained 
with DAPI to visualize nucleus. The images were taken using a Leica DMI 6000 B 
fluorescence microscope. Bar, 20 μm. 
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               To further confirm the localization of Cx46, untransfected, stable or transiently 
transfected cells were fractionated to isolate plasma membrane proteins. Western blot 
analyses with antibodies against GFP or Cx46 detected no immunoreactive bands that 
corresponded to endogenous Cx46 or Cx46-GFP protein in the plasma membrane 
fraction of untransfected or transfected NN1003A cells (Figure 3.3A). In all the 
preparations of plasma membrane fractions, the marker for plasma membrane (Na+-K+ 
ATPase) was detected but not the marker for cytosol (Glyceraldehyde 3-phosphate 
dehydrogenase, GAPDH) or endoplasmic reticulum (Calnexin), confirming the purity of 
the fractions (Figure 3.3A). 
 
               The GFP protein has a molecular weight of 27 kDa. Therefore I speculated 
whether GFP tagging at C-terminal of Cx46 prevents it from reaching the cell surface. 
To investigate this, I transfected cells with plasmid encoding Cx46-His (Histidine- 
tagged) and examined the localization of Cx46 –His fusion protein in order to see if 
tagging with a smaller molecule affects the localization of Cx46. Immunofluorescence 
studies, using anti-His antibody, also demonstrated the localization of Cx46 
predominantly to the intercellular compartments (Figure 3.3C). To further demonstrate 
that GFP-tagging does not affect the localization of connexin proteins in NN1003A cells, 
cells were transiently transfected to express Cx43-GFP. Using western blot analysis, 
Cx43-GFP fusion protein (around 70 kDa) was detected in plasma membrane fractions 
isolated from Cx43-GFP overexpressing NN1003A cells (Figure 3.3B). These data 
clearly suggested that GFP tagging had no influence on the Cx46 transportation to the 
cell membrane. It has also been previously shown that C-terminal tagging of connexin 
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does not alter membrane transport (Paemeleire, Martin et al. 2000; Thomas, Jordan et 
al. 2005). 
 
Figure 3.3 Cx46 protein is predominantly localized to the intercellular 
compartments in lens NN1003A cells.  
(A) Western blot analyses were performed for Cx46 (with anti-GFP or anti-Cx46) on 
equal amounts of total protein from lysates of Cx46-GFP expressing cells (stable 
transfection) and plasma membrane protein fractions from untransfected (NN) or Cx46-
GFP stably overexpressing cells. The blots were also probed with antibodies against a 
plasma membrane marker Na+-K+ ATPase, and a cytosolic marker (GAPDH) to 
demonstrate the purity of plasma membrane protein extracts. (B) Western blot analyses 
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show the localization of Cx43 in the plasma membrane of Cx43 GFP expressing cells. 
Cells were transiently transfected with plasmid encoding Cx43-GFP for 24 hr. Then the 
cells were fractionated into plasma membrane protein fraction. Equal amounts of total 
protein of lysate and plasma membrane fraction of Cx43-GFP expressing cells were 
subjected to western blot analyses with antibodies against GFP, Na+-K+ ATPase and 
GAPDH and an ER marker (calnexin). (C) The localization of Cx46-His protein 
(Histidine-tagged) in NN1003A cells. Cells were transfected with plasmid encoding 
Cx46-His. After 24 and 48 hr of transfection, cells were fixed, permeabilized and stained 
with anti-Cx43 antibody (red) and DAPI. Images were taken using a Leica DMI 6000 B 
fluorescence microscope. Bar, 20 μm. 
 
 3.3.3. Overexpression of Cx46 does not alter Cx43 message level 
 
Next, we investigated whether Cx43 degradation was pre or post-transcriptionally 
initiated in Cx46 overexpressing NN1003A cells. To check this, reverse transcription 
(RT)-PCR was carried out to detect the Cx43 transcript levels in cells stably or 
transiently overexpressing Cx46-GFP. The results of the RT-PCR experiments are 
shown in Figure.3.4. The overexpression of Cx46 did not cause a change in the Cx43 
message level indicating the occurrence of post-transcriptional regulation of Cx43. 
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Figure 3.4 RT-PCR analyses of Cx43 mRNA levels in NN1003A cells 
overexpressing Cx46.  
Total RNA was isolated from (A) stably or (B) transiently transfected cells followed by 
RT-PCR using specific primers for Cx43 cDNA and β-actin cDNA (internal control). For 
transient transfection, total RNA was isolated at 0, 12, 24, 36 and 48 hr after 
transfection with plasmid encoding Cx46-GFP. The numbers of cycles of PCR are given 
in the figure.  
 
 3.3.4. Overexpression of Cx50 protein has no effect on Cx43 protein level. 
 
               Another connexin protein expressed in lens is connexin50 (Cx50). Cx50 is 
expressed in lens epithelial as well as in fiber cells. Therefore I examined the effect of 
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overexpression of Cx50 on Cx43 protein levels. The cells were stably or transiently 
transfected with plasmid encoding Cx50-GFP for 12, 24, 36 and 48 h. Overexpression 
of Cx50 had no effect on Cx43 protein levels at 12-48 hr after transfection (Figure 3.5, 
left). Stable overexpression of Cx50-GFP also showed the similar effect with no change 
in Cx43 protein levels (Figure 3.5, right).Collectively, the above results suggested that 
Cx50, unlike Cx46, was unable to induce Cx43 degradation. 
 
Figure 3.5 Overexpression of Cx50 does not cause a decrease in Cx43 protein 
levels. 
 NN1003A cells were transiently (left) or stably (right) transfected with plasmid encoding 
Cx50-GFP. Cell lysates were prepared and equal amounts of total protein were run in to 
SDS-PAGE followed by western blot. The Cx50-GFP and Cx43 proteins were detected 
by probing the blots with anti-GFP and anti-Cx43 antibodies, respectively. 
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 3.3.5. Treatment with proteasome inhibitors restores Cx43 protein level 
while lysosomal inhibitors have no effect 
 
               Next I investigated the pathway that is involved in the degradation of Cx43 
upon Cx46 overexpression. Cx43 degradation have been reported to be mediated by 
both lysosomal and proteasomal pathways. To identify which proteolytic degradation 
pathway is involved, I treated stably transfected cells with a series of inhibitors for both 
lysosome and proteasome and analyzed their effect on Cx43 degradation by western 
blot. Treatment with the lysosome inhibitor, leupeptin, did not cause a change in the 
Cx46-induced loss of Cx43 (Figure 3.6A, lane 4). Treatment with another lysosome 
inhibitor, chloroquine, or delivery vehicle DMSO showed the same result as no change 
in the reduced levels of Cx43 was observed (Figure 3.6B-C, lane 4). However, when 
stably transfected cells were incubated with proteasomal inhibitor, ALLN (N-Acetyl-Leu-
Leu-Nle-CHO), Cx43 protein levels were not reduced (Figure 3.7A). Treatment with 
ALLN restored all three forms of Cx43 protein (Cx43-P0, P1 and P2) to the levels of 
Cx43 protein in control untransfected cells (Figure 3.7A-B). The restoration of Cx43 
protein levels, due to the addition of the proteasome inhibitor, was further confirmed by 
treating the cells with another proteasomal inhibitor MG132. Expectedly, the Cx46-
induced loss of Cx43 was strongly counteracted in Cx46-GFP expressing NN1003A 
cells (Figure 3.7A). Together, these results suggested that the proteasome was the 
major site where Cx43 was degraded due to overexpression of Cx46.  
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Figure 3.6 Treatment with lysosome inhibitors has no effect on Cx46-induced 
degradation of Cx43.  
Untransfected control and Cx46-GFP stably transfected cells were treated with 
lysosome inhibitors (A) leupeptin (200 uM) or (B) chloroquine (200 uM) or (C) vehicle 
(DMSO) for 4 hr. Cell lysates were prepared and equal amounts of total protein were 
analyzed by western blot using antibody against Cx43 (anti-Cx43 CT) and β-actin 
(loading control). Lanes 1 and 2: Untransfected (control) cells.  Lanes 3 and 4: Cx46-
GFP stably transfected cells.  
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Figure 3.7 Treatment with proteasomal inhibitors counteracts Cx46-induced loss 
of Cx43. 
 (A) Control or Cx46-GFP stably transfected NN1003A cells were treated with 
proteasomal inhibitors, ALLN (100uM) or MG-132 (10uM), for 4 hr. Cell lysates were 
prepared and equal amounts of total cell protein in each cell lysate were analyzed by 
western blot with antibodies against Cx43 (anti-Cx43 CT) and β-actin (loading control)  
(B) Densitometric analyses show that the treatment with ALLN or MG-132 restored 
Cx43 protein levels in Cx46-GFP expressing cells. Cx43 and β-actin bands were 
digitized by UN-SCAN-It gel software. The average pixel value was calculated for each 
Cx43 band, normalized and plotted in % of control (β-actin). Asterisk (*) indicates 
144 
 
significant statistical difference (P<0.05) between indicated data and Cx46-GFP 
expressing untreated cell (double asterisk **) 
 
 3.3.6. Overexpression of Cx46 increases Cx43 ubiquitination 
 
               Proteasomal degradation may involve direct proteolysis or ubiquitin-mediated 
degradation of targeted protein. Binding of ubiquitin has been previously shown to serve 
as an important signal in the regulation of Cx43 localization and turnover (Leithe and 
Rivedal 2004; Leithe, Kjenseth et al. 2009). To determine if Cx46-induced Cx43 
degradation is initiated by ubiquitin conjugation, first, Cx43 was immunoprecipitated 
from untransfected or GFP or Cx46-GFP stably transfected cells using anti-Cx43 CT 
antibody. Immunoprecipitated samples were then analyzed for the presence of 
ubiquitinated Cx43 by western blot using anti-ubiquitin antibody. As a positive control, 
anti-ubiquitin antibody was able to recognize purified ubiquitin ladder (polymerized 
ubiquitin chain through lysine 48) (Figure 3.8B). In non-transfected (control) and GFP 
(only) transfected cells, a faint ladder of ubiquitin bands of high molecular weight 
(between 50-75 kDa regions), characteristic of polyubiquitinated Cx43, was observed 
(Figure 3.3A, lanes 2 and 3). I also wanted to investigate whether Cx50 overexpression 
has any effect on Cx43 ubiquitination level. Stable or transient overexpression of Cx50 
showed the presence of similar ubiquitin ladder with faint intensities (Figure 3.3A, lanes 
4 and 5). But interestingly, cells stably overexpressing Cx46-GFP demonstrated a 
ladder of ubiquitin bands with strong intensities at the same region of the blot (Figure 
3.3A, lane 6). However, in the negative control sample, where cell lysate made from 
Cx46-GFP expressing cells was immunoprecipitated with a rabbit non-specific IgG, 
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ubiquitin bands were not detected (Figure 3.3A, lane1). These data indicated that Cx46 
overexpression caused an increase in the ubiquitination of Cx43.   
  
               To further confirm that the presence of ubiquitin ladders in the 
immunoprecipitated samples represented actual ubiquitinated-Cx43 and did not result 
because of nonspecific interactions of the antibody, I preincubated anti-ubiquitin 
antibody with the purified ubiquitin ladder (Figure 3.3B) and used this neutralized 
antibody to stain ubiquitinated Cx43 in anti-Cx43 antibody immunoprecipitated samples 
on the western blot. The anti-ubiquitin antibody binds to purified ubiquitin ladder and 
therefore would not be available to bind ubiquitinated Cx43 on the western blot. Indeed, 
the ladder of bands (over 50 kDa region), characteristics of ubiquitinated Cx43 in Cx46-
GFP expressing cells, was not seen when anti-ubiquitin antibody was preincubated with 
the purified ubiquitin ladder (Figure 3.8C). The band at 50 kDa region was probably 
resulted because of cross reactivity of the secondary antibody with IgG. Collectively, 
these data suggested that the overexpression of Cx46 induced ubiquitin binding to Cx43 
leading to Cx43 degradation by the proteasome pathway. 
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Figure 3.8 Overexpression of Cx46 increases ubiquitination of Cx43.  
(A) Lysates from untransfected (NN) cells (lane 2) or GFP (lane 3), Cx50-GFP (lane 4), 
Cx46-GFP (lane 6) stably transfected or Cx50-GFP transiently transfected cells (36 hr, 
lane 5) were prepared and subjected to immunoprecipitation by rabbit anti-Cx43 
antibody (anti-Cx43 CT). Equal amounts of immunoprecipitated samples were loaded 
into 8% SDS-PAGE. Ubiquitinated Cx43 were detected by immunoblotting using anti-
ubiquitin antibody. As a negative control, cell lysate, made from Cx46-GFP expressing 
cells, was immunoprecipitated with a rabbit non-specific IgG. The same blot was 
stripped and reprobed with anti-Cx43 antibody (anti-Cx43CT) to show equal loading of 
immunoprecipitates. A band observed at 50 kDa region in the negative control sample 
was probably resulted from cross reactivity of the secondary antibody to IgG. (B) As a 
positive control of anti-ubiquitin antibody, a commercially available purified ubiquitin 
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ladder (ubiquitin is polymerized through lysine 48) was subjected to 15 % SDS-PAGE. 
Western blot was performed and probed with anti-ubiquitn antibody. (C) Anti-Cx43 (anti-
Cx43CT) immunoprecipitate samples were made from Cx46-GFP expressing cells and 
subjected to SDS-PAGE and analyzed by western blotting with anti-ubiquitin antibody 
that was preincubated with the ubiquitin ladder or buffer. The Cx43-ubiqtuin bands were 
not detected when anti-ubiquitin antibody was preincubated with ubiquitin ladder. 
 3.3.7. Cx46 colocalizes with Cx43 in Cx46-GFP expressing stable cells 
 
               To further explore the mechanism involved in the Cx46-induced loss of Cx43, I 
investigated whether Cx46 interacts with Cx43 in stably transfected cells by 
imuunofluorescence-confocal microscope study. Staining NN1003A control 
(untransfected) or GFP transfected cells with anti-Cx43 antibody (red) showed Cx43 
gap-junctional staining at cell-cell interfaces (Figure 3.9). However Cx43 gap junctions 
had disappeared in Cx46-GFP stably transfected cells and Cx43 staining was only 
observed in the cytoplasm. In these cells, green signal representing Cx46-GFP was 
mainly distributed in the intercellular compartments with no apparent membrane signal 
being visible (Figure 3.9). The merged figure showed co-localization of Cx46 and Cx43 
(yellow) to the intercellular compartments. However, staining NN1003A control cells with 
anti-Cx46 (Figure 3.9 a) and anti-Cx43 antibody showed no significant co-localization 
between endogenous Cx46 and Cx43. These data suggested that Cx46, only upon 
overexpression, co-localized with Cx43. 
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Figure 3.9 Cx46 colocalizes with Cx43 in stably transfected cells.  
GFP (b) or Cx46-GFP stably (c) transfected NN1003A cells were fixed in 
paraformaldehyde, permeabilized and stained with anti-Cx43 (red). The untransfected 
control cells were also fixed, permeabilized and stained with anti-Cx46 (to visualize 
endogenous Cx46, green) and anti-Cx43 antibodies. The images were taken using a 
Nikon C1 scanning confocal microscope. The overexpression of GFP (b) or Cx46-GFP 
(c) was visualized by green fluorescence only.  White solid arrows indicate Cx43 gap 
junctions in the image. Broken white arrows indicate co-localization (yellow) of Cx46 
and Cx43 in cells stably overexpressing Cx46-GFP. The inset (white) has been 
enlarged (blue arrow) where co-localization is more evident. 
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 3.3.8. Carboxyl (C-) terminal tail of Cx46 is required for Cx43 degradation 
 
              Next, we asked which part of the Cx46 protein is required to induce Cx43 
degradation. Like other connexins, Cx46 also has four transmembrane domains with a 
short N-terminal and relatively long C-terminal domain within the cytoplasm. Amino acid 
sequence alignments of rat Cx46 and Cx50 shows significant sequence similarity with 
the highest variability observed at the C-terminal tail region (Figure 3.11). Since Cx50 
overexpression was not found to mediate Cx43 degradation I speculated whether the C-
terminal tail region (amino acid 225-416) is the active part of Cx46 that induces Cx43 
degradation. To test this hypothesis I transfected NN003A cells with plasmid encoding 
Cx46 GFP tagged C-terminal tail deletion (residues 232-416) mutant (Cx46-dCT-GFP, 
Figure 3.10 A) and analyzed the effect of overexpression of mutant Cx46 protein on 
Cx43 protein levels (Figure 3.10B). Cx46-dCT-GFP was expressed at predicted 
molecular weight of ∼50 kDa as determined by western blot using anti-GFP antibody 
(Figure 3.10B). As seen in the figure 3.10B, overexpression of Cx46 deletion mutant did 
not induce Cx43 degradation at 24-48 hr after transfection. This was further confirmed 
by immunofluorescence-confocal microscope studies where Cx43 gap junctions were 
observed in the cells overexpressing C-terminal Cx46 deletion mutant (Figure 3.10C). In 
these cells, cytoplasmic localization of Cx43 or co-localization with Cx46 was not seen 
(Figure 3.10C). These data clearly suggested that deletion of C-terminal tail rendered 
Cx46 mutant ineffective to co-localize and degrade Cx43. 
 
150 
 
 
 
Figure 3.10 The C-terminal region of Cx46 is required to induce Cx43 degradation.  
(A) Schematic diagram of wild type Cx46 and C-terminal (CT) deletion (amino acid 225-
416) Cx46 mutant (Cx46-dCT). The cDNA corresponding to Cx46-dCT was sub-cloned 
into pEGFP-N3 vector to get Cx46-dCT-GFP (B) Overexpression of Cx46 deletion 
mutant (Cx46-dCT) does not induce Cx43 degradation. Western blot analyses of Cx46-
dCT mutant (GFP tagged) and Cx43 in untransfected cells (0hr) or in cells transiently 
transfected with plasmid encoding Cx46 deletion mutant (Cx46-dCT-GFP). The 
expression of Cx46-dCT-GFP was confirmed by probing the blot with anti-GFP 
antibody. The blot was also probed with anti-Cx43 CT and β-Actin antibodies.  
(C) Immunofluorescence-confocal images of Cx43 and Cx46-dCT-GFP in NN1003A 
cells. Cells were transfected with plasmid encoding Cx46-dCT-GFP for 36 hr. Cells 
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were fixed, permeabilized and stained with anti- Cx43 antibody. The images were taken 
using a Nikon C1 scanning confocal microscope. 
 
 3.4. Discussion  
 
 In this study I demonstrated a novel role of gap junction Cx46 protein in the 
regulation of turnover of another gap junction protein Cx43. Using a well-characterized, 
long-term lens epithelial cell culture overexpressing Cx46, I found Cx46-induced 
degradation of Cx43 (Figure 3.1). I confirmed reduction in the levels of all three forms of 
Cx43 (nonphosphorylated P0 and phosphorylated P1 and P2) protein by western 
blotting with antibodies against C-terminal and N-terminal region (Figure 3.1 A). The 
cleavage of Cx43 C-terminal fragments has been reported to occur in lens fiber cells, 
therefore, antibody against N-terminal region of Cx43 was also used to confirm  
degradation (Mathias, White et al. 2010). Our data also showed that the protein 
expression of another major lens connexin, Cx50, was not altered upon Cx46 
overexpression (Figure 3.1 A-C). In addition, overexpression of Cx50 protein did not 
induce degradation of Cx43 (Figure 3.5). Collectively, these indicate that only Cx46, 
when overexpressed, can stimulate Cx43 degradation which another connexin, Cx50, 
cannot do. 
 
               The reduction of Cx43 protein due to the Cx46 overexpression is not 
pre-transcriptionally initiated as Cx43 mRNA level was not changed as determined by 
RT-PCR experiments. (Figure 3.4) Therefore, I investigated the proteolytic pathway that 
is involved in the degradation. Several studies have reported previously that Cx43 are 
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degraded via both lysosome and proteasome. The lysosomal pathway was shown to be 
involved in the degradation of Cx43 when it is internalized from cell membrane 
(Berthoud, Minogue et al. 2004; Leithe and Rivedal 2004). Treatment with protease 
inhibitors such as leupeptin, which inhibits cathepsin B, H and L (Leithe and Rivedal 
2004), and chloroquine, which is another well know lysosome inhibitor(Gonzalez-
Noriega, Grubb et al. 1980; Qin, Shao et al. 2003; Marques, Pereira et al. 2004), 
showed no effect in the degradation of Cx43 in Cx46-GFP expressing cells (Figure 3.6). 
But, the treatment with a proteasome inhibitor, ALLN, strongly counteracted Cx46-
induced Cx43 degradation (Figure 3.7). ALLN is widely used for proteasome inhibition 
studies (Griscavage, Wilk et al. 1996; Hughes, Ortmann et al. 1996; Laing, Tadros et al. 
1998; Musil, Le et al. 2000), however, ALLN can also inhibit some non-proteasomal 
enzymes such as calpains and cathepsins (Boswell, Le et al. 2009). I therefore treated 
the cells with another very potent and widely used proteasome inhibitor, MG132 
(Mailhes, Hilliard et al. 2002; Leithe and Rivedal 2004; Leithe and Rivedal 2004; 
Alexandrova, Petrov et al. 2008). The effect of MG132 treatment was identical, as seen 
with ALLN, where Cx43 protein levels were restored to normal in Cx46-GFP stably 
transfected cells (Figure 3.7).  
 
               Conjugation of ubiquitin serves as a signal for targeting protein to the 
proteasome for degradation. The ubiquitin-proteasome pathways mediates the 
degradation of several proteins that are localized to the different compartments of cells 
and are involved in signal transduction or other cellular processes (Hershko and 
Ciechanover 1998). Cx43 has also been previously reported to undergo 
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polyubiquitination under stress conditions. Tumor-promoting protein kinase C (PKC)-
activator, phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), has been shown 
to cause Cx43 ubiquitination and subsequent proteasomal degradation (Leithe and 
Rivedal 2004). Therefore I looked into the Cx43 ubiquitination status in the cells 
overexpressing Cx46 by co-immunoprecipitation analyses. Interestingly, an increase in 
Cx43 ubiquitination was only found in Cx46-GFP expressing cells (Figure 3.8). 
Together, these results suggest that Cx46-induced degradation of Cx43 is mediated by 
the ubiquitin-proteasome pathway while the lysosome does not appear to be involved. 
 
               In this study, I observed that Cx46 is mainly localized to the intercellular 
compartments of rabbit lens epithelial NN1003A cells (Figure 3.2). Even upon 
overexpression, localization of Cx46 was not detected in the plasma membrane, as 
determined by immunofluorescence-confocal microscope study (Figure 3.2) and 
western blot analyses of plasma membrane protein fractions (Figure 3.3A). Cx46 was 
shown to form  gap junction channels in lens fiber cells which are differentiated from 
epithelial cells (Mathias, White et al. 2010). Our lab has also found endogenous Cx46 
protein localization to the intercellular compartments in human lens epithelial cells 
(HLEC) (Satyabrata Das thesis, 2010) in culture. In the previous chapter, I have 
observed a similar Cx46 localization in breast cancer MCF-7 cells. The intercellular 
localization of Cx46 was also shown in bone osteoblastic (Koval, Harley et al. 1997) and 
lung alveolar cells (Abraham, Chou et al. 1999). Conventional techniques such as 
immunofluorescence and western blot do not completely rule out the possibility of 
membrane localization of Cx46. Connexins have rapid turnover rates with half-lives of 
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few hours. Therefore, if Cx46 is rapidly internalized after being delivered to the plasma 
membrane it would not be detectable at the cell surface by conventional indirect 
immunofluorescence. Nonetheless, since membrane localization was not appeared, it is 
unlikely that overexpression of Cx46 induced Cx43 degradation by facilitating its 
internalization from the plasma membrane. Our study also showed that Cx43 co-
localized with Cx46 in only stably transfected cells at intercellular region (Figure 3.9). 
However endogenous Cx46 was not found to co-localize with Cx43 (Figure 3.9 a). 
These results suggest that Cx46, when endogenously expressed is not involved in Cx43 
turnover, but, when overexpressed, can interact with Cx43 possibly at intercellular 
compartments and induce its degradation by ubiquitin-proteasome pathway. 
 
                Cx50 is another connexin that is highly expressed in lens. As mentioned 
before, though Cx46 is upregulated and Cx43 is downregulated during lens epithelial to 
fiber cell differentiation, Cx50 level remains unchanged. I found that, unlike Cx46, 
overexpression of Cx50 did not induce Cx43 degradation. Amino acid sequence-
alignment shows that Cx46 shares high sequence similarity with Cx50. Considerable 
sequence variability is observed only at the C-terminal region of the two proteins 
(residues 230-416 for Cx46 and residues 230-440 for Cx50) (Figure 3.11). The 
functional properties of connexins are regulated by the post-translational modifications 
of their C-terminal tail region which shows little sequence homology among different 
connexin isoforms. Phosphorylation of Cx43 at S-262 has been reported to regulate the 
inhibition of DNA synthesis in primary cardiomyocytes (Dang, Jeyaraman et al. 2006). 
C-terminal region of Cx32 has been shown to be involved in the inhibition of malignant 
155 
 
phenotypes of human metastatic renal cell carcinoma cell line (Caki-1) mainly through 
the inactivation of Src signaling (Fujimoto, Sato et al. 2005). In the present study, I have 
shown that the C-terminal tail of Cx46 is required to induce Cx43 downregulation. Cx43 
protein levels were not reduced in the cells expressing Cx46 C–terminal tail deletion 
mutant (Cx46-dCT). The localization of the Cx46-dCT mutant protein was similar to the 
wild type Cx46, predominantly to the intercellular compartments, but, mutant protein did 
not co-localize with Cx43. Collectively, these results also indicate that the Cx46 C-
terminal tail is required for co-localization with Cx43 to mediate degradation by the 
ubiquitin-proteasome pathway. 
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Figure 3.11 Protein sequence alignment of rat Cx46 and Cx50.  
The amino acid residues that are present in both Cx46 and Cx50 are given in colors or 
bold black .The red line (dotted) represents the start of C-terminal region The NCBI 
reference sequences are NP_077352.1 for Cx46 and NP_703195.2 for Cx50. 
  
 
               Cx43 has been shown previously to be ubiquitinated by the action of the 
enzyme Nedd4, an E3 ubiquitin ligase (Leykauf, Salek et al. 2006; Girao, Catarino et al. 
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2009). Nedd4 mediates ubiquitin-dependent degradation of target proteins that have PY 
motif (PPxY) (Ingham, Gish et al. 2004). Cx43 has a Nedd4 binding site (PY motif) at its 
C-terminal region (S282PPGY286) that binds to Nedd4 which is recruited by the MAPK 
dependent pathway (Figure 3.10). The C-terminal consensus PY motif of Cx43 contains 
a nearby lysine residue (S282PPGYKLV289). It is speculated that when Nedd4 binds to 
Cx43 at the C-terminal region, it ubiquitinates the nearby lysine (Lys 288) and targets 
Cx43 for proteasomal degradation. Nedd4 has been found to co-localize with Cx43 both 
at plasma membrane and intercellular compartments. Cx46 has a PY motif 
(274LPPYY279) at its C-terminal end but the nearby lysine residue is missing whereas 
Cx50 lacks any such analogous binding site for Nedd4. Therefore, I speculate that in 
Cx46-GFP expressing cell, Cx46 binds to Nedd4 and delivers it to Cx43 during when it 
co-localizes with Cx43 in the intercellular compartments. The enhanced interaction of 
Nedd4 with Cx43 results in increased ubiquitination and degradation of Cx43 by the 
ubiquitin-proteasome pathway This could also explain why Cx50 or Cx46-dCT-GFP 
overexpression does not cause Cx43 degradation as they do not have the binding motif 
for Nedd4. The wild-type Cx46-GFP contains binding motif for Need4 (274LPPYY279) but 
it is not degraded as it lacks the nearby critical lysine residue for ubiquitnation. Further 
studies with Cx46 mutants, defectives in Nedd4 binding, are required to investigate the 
above hypothesis. 
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Figure 3.12 The protein sequence of rat Cx43 protein (NCBI Reference Sequence: 
NP_036699.1).  
The Nedd4 binding site has been shown in blue and critical lysine residue has been 
shown in black. 
 
 
               Our results will help gain a better knowledge of the lens epithelial-to-fiber cell 
differentiation and the role that connexins play in this process. Lens differentiation 
process has been shown to involve several growth factors such as fibroblast growth 
factors (FGF), Wingless (Wnt), transforming growth factor-Beta (TGF-β) proteins (de 
Iongh, Lovicu et al. 2001; Lyu and Joo 2004), as well as several cell signaling pathways, 
including mitogen activated protein kinase (MAPK) signaling (Wang, Stump et al. 2009). 
However the role of connexins in the lens differentiation process is largely elusive. Our 
study indicates that Cx46 might play a major role in lens differentiation by enhancing 
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Cx43 degradation. Our lab has also found that the over expression of Cx46, in addition 
to inducing Cx43 degradation, elicits morphological changes in lens epithelial cells that 
resemble fiber cells (Takemoto lab, unpublished data). Our results will also help 
understand the connexins mediated regulation of breast tumorigenesis. As mentioned in 
the previous chapters, Cx43 has anti-tumor properties and expression of Cx43 is 
downregulated in breast tumors, the molecular mechanism of which is not clearly 
known. In Chapter 2 of this dissertation, I have shown that Cx46 is upregulated in breast 
tumors and favors tumor growth. Therefore I speculate that Cx46 promotes breast 
tumor growth by inducing the degradation of the tumor suppressor protein Cx43.  
 
              In conclusion our data indicate that overexpression of Cx46 induces the 
degradation of another connexin, Cx43. Cx46, upon overexpression, co-localizes with 
Cx43. I also provide evidence that the C-terminal tail of Cx46 is essential for co-
localization and Cx46-induced degradation of Cx43. The ubiquitination of Cx43 is 
strongly increased in Cx46-GFP expressing cells and proteasomal inhibitors counteract 
the Cx43 degradation Therefore Cx46-induced Cx43 degradation is likely to be 
mediated via the ubiquitn-proteasome pathway.  
 
 
  
 
160 
 
  
 3.5. References 
 
Abraham, V., M. L. Chou, et al. (1999). "Phenotypic control of gap junctional 
communication by cultured alveolar epithelial cells." Am J Physiol
Alexandrova, A., L. Petrov, et al. (2008). "Effects of proteasome inhibitor, MG132, on 
proteasome activity and oxidative status of rat liver." 
 276(5 Pt 1): 
L825-834. 
Cell Biochem Funct
Bassnett, S. (2002). "Lens organelle degradation." 
 26(3): 
392-398. 
Exp Eye Res
Bennett, M. V. and V. K. Verselis (1992). "Biophysics of gap junctions." 
 74(1): 1-6. 
Semin Cell Biol
Berthoud, V. M. and E. C. Beyer (2009). "Oxidative stress, lens gap junctions, and 
cataracts." 
 
3(1): 29-47. 
Antioxid Redox Signal
Berthoud, V. M., P. J. Minogue, et al. (2004). "Pathways for degradation of connexins 
and gap junctions." 
 11(2): 339-353. 
Cardiovasc Res
Boswell, B. A., A. C. Le, et al. (2009). "Upregulation and maintenance of gap junctional 
communication in lens cells." 
 62(2): 256-267. 
Exp Eye Res
Bukauskas, F. F. and V. K. Verselis (2004). "Gap junction channel gating." 
 88(5): 919-927. 
Biochim 
Biophys Acta
Ciechanover, A. (1998). "The ubiquitin-proteasome pathway: on protein death and cell 
life." 
 1662(1-2): 42-60. 
EMBO J 17(24): 7151-7160. 
161 
 
Crow, D. S., E. C. Beyer, et al. (1990). "Phosphorylation of connexin43 gap junction 
protein in uninfected and Rous sarcoma virus-transformed mammalian 
fibroblasts." Mol Cell Biol
Dahm, R., J. van Marle, et al. (1999). "Gap junctions containing alpha8-connexin 
(MP70) in the adult mammalian lens epithelium suggests a re-evaluation of its 
role in the lens." 
 10(4): 1754-1763. 
Exp Eye Res
Dang, X., M. Jeyaraman, et al. (2006). "Regulation of connexin-43-mediated growth 
inhibition by a phosphorylatable amino-acid is independent of gap junction-
forming ability." 
 69(1): 45-56. 
Mol Cell Biochem
de Iongh, R. U., F. J. Lovicu, et al. (2001). "Requirement for TGFbeta receptor signaling 
during terminal lens fiber differentiation." 
 289(1-2): 201-207. 
Development
Donaldson, P., J. Kistler, et al. (2001). "Molecular solutions to mammalian lens 
transparency." 
 128(20): 3995-4010. 
News Physiol Sci
Fallon, R. F. and D. A. Goodenough (1981). "Five-hour half-life of mouse liver gap-
junction protein." 
 16: 118-123. 
J Cell Biol
Fujimoto, E., H. Sato, et al. (2005). "Connexin32 as a tumor suppressor gene in a 
metastatic renal cell carcinoma cell line." 
 90(2): 521-526. 
Oncogene
Girao, H., S. Catarino, et al. (2009). "Eps15 interacts with ubiquitinated Cx43 and 
mediates its internalization." 
 24(22): 3684-3690. 
Exp Cell Res
Goldberg, G. S., V. Valiunas, et al. (2004). "Selective permeability of gap junction 
channels." 
 315(20): 3587-3597. 
Biochim Biophys Acta 1662(1-2): 96-101. 
162 
 
Gonzalez-Noriega, A., J. H. Grubb, et al. (1980). "Chloroquine inhibits lysosomal 
enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing 
receptor recycling." J Cell Biol
Goodenough, D. A., J. A. Goliger, et al. (1996). "Connexins, connexons, and 
intercellular communication." 
 85(3): 839-852. 
Annu Rev Biochem
Griscavage, J. M., S. Wilk, et al. (1996). "Inhibitors of the proteasome pathway interfere 
with induction of nitric oxide synthase in macrophages by blocking activation of 
transcription factor NF-kappa B." 
 65: 475-502. 
Proc Natl Acad Sci U S A
Harris, A. L. (2001). "Emerging issues of connexin channels: biophysics fills the gap." 
 93(8): 3308-3312. 
Q 
Rev Biophys
Hershko, A. and A. Ciechanover (1992). "The ubiquitin system for protein degradation." 
 34(3): 325-472. 
Annu Rev Biochem
Hershko, A. and A. Ciechanover (1998). "The ubiquitin system." 
 61: 761-807. 
Annu Rev Biochem
Herve, J. C., M. Derangeon, et al. (2007). "The connexin turnover, an important 
modulating factor of the level of cell-to-cell junctional communication: comparison 
with other integral membrane proteins." 
 67: 
425-479. 
J Membr Biol
Hirschi, K. K., C. E. Xu, et al. (1996). "Gap junction genes Cx26 and Cx43 individually 
suppress the cancer phenotype of human mammary carcinoma cells and restore 
differentiation potential." 
 217(1-3): 21-33. 
Cell Growth Differ
Hughes, E. A., B. Ortmann, et al. (1996). "The protease inhibitor, N-acetyl-L-leucyl-L-
leucyl-leucyl-L-norleucinal, decreases the pool of major histocompatibility 
 7(7): 861-870. 
163 
 
complex class I-binding peptides and inhibits peptide trimming in the 
endoplasmic reticulum." J Exp Med
Ingham, R. J., G. Gish, et al. (2004). "The Nedd4 family of E3 ubiquitin ligases: 
functional diversity within a common modular architecture." 
 183(4): 1569-1578. 
Oncogene
Koval, M., J. E. Harley, et al. (1997). "Connexin46 is retained as monomers in a trans-
Golgi compartment of osteoblastic cells." 
 23(11): 
1972-1984. 
J Cell Biol
Laing, J. G. and E. C. Beyer (1995). "The gap junction protein connexin43 is degraded 
via the ubiquitin proteasome pathway." 
 137(4): 847-857. 
J Biol Chem
Laing, J. G., P. N. Tadros, et al. (1998). "Proteolysis of connexin43-containing gap 
junctions in normal and heat-stressed cardiac myocytes." 
 270(44): 26399-26403. 
Cardiovasc Res
Laing, J. G., P. N. Tadros, et al. (1997). "Degradation of connexin43 gap junctions 
involves both the proteasome and the lysosome." 
 38(3): 
711-718. 
Exp Cell Res
Laird, D. W. (1996). "The life cycle of a connexin: gap junction formation, removal, and 
degradation." 
 236(2): 482-492. 
J Bioenerg Biomembr
Laird, D. W. (2006). "Life cycle of connexins in health and disease." 
 28(4): 311-318. 
Biochem J
Laird, D. W., P. Fistouris, et al. (1999). "Deficiency of connexin43 gap junctions is an 
independent marker for breast tumors." 
 394(Pt 
3): 527-543. 
Cancer Res
Laird, D. W., K. L. Puranam, et al. (1991). "Turnover and phosphorylation dynamics of 
connexin43 gap junction protein in cultured cardiac myocytes." 
 59(16): 4104-4110. 
Biochem J 273(Pt 
1): 67-72. 
164 
 
Lampe, P. D. and A. F. Lau (2000). "Regulation of gap junctions by phosphorylation of 
connexins." Arch Biochem Biophys
Larsen, W. J. and N. Hai (1978). "Origin and fate of cytoplasmic gap junctional vesicles 
in rabbit granulosa cells." 
 384(2): 205-215. 
Tissue Cell
Lecker, S. H., A. L. Goldberg, et al. (2006). "Protein degradation by the ubiquitin-
proteasome pathway in normal and disease states." 
 10(3): 585-598. 
J Am Soc Nephrol
Lee, S. W., C. Tomasetto, et al. (1992). "Transcriptional downregulation of gap-junction 
proteins blocks junctional communication in human mammary tumor cell lines." 
 17(7): 
1807-1819. 
J 
Cell Biol
Leithe, E., A. Kjenseth, et al. (2009). "Ubiquitylation of the gap junction protein 
connexin-43 signals its trafficking from early endosomes to lysosomes in a 
process mediated by Hrs and Tsg101." 
 118(5): 1213-1221. 
J Cell Sci
Leithe, E. and E. Rivedal (2004). "Epidermal growth factor regulates ubiquitination, 
internalization and proteasome-dependent degradation of connexin43." 
 122(Pt 21): 3883-3893. 
J Cell Sci
Leithe, E. and E. Rivedal (2004). "Ubiquitination and down-regulation of gap junction 
protein connexin-43 in response to 12-O-tetradecanoylphorbol 13-acetate 
treatment." 
 
117(Pt 7): 1211-1220. 
J Biol Chem
Leykauf, K., M. Salek, et al. (2006). "Ubiquitin protein ligase Nedd4 binds to connexin43 
by a phosphorylation-modulated process." 
 279(48): 50089-50096. 
J Cell Sci
Loewenstein, W. R. (1979). "Junctional intercellular communication and the control of 
growth." 
 119(Pt 17): 3634-3642. 
Biochim Biophys Acta 560(1): 1-65. 
165 
 
Lyu, J. and C. K. Joo (2004). "Wnt signaling enhances FGF2-triggered lens fiber cell 
differentiation." Development
Mailhes, J. B., C. Hilliard, et al. (2002). "MG-132, an inhibitor of proteasomes and 
calpains, induced inhibition of oocyte maturation and aneuploidy in mouse 
oocytes." 
 131(8): 1813-1824. 
Cell Chromosome
Marques, C., P. Pereira, et al. (2004). "Ubiquitin-dependent lysosomal degradation of 
the HNE-modified proteins in lens epithelial cells." 
 1(1): 2. 
FASEB J
Mathias, R. T., T. W. White, et al. (2010). "Lens gap junctions in growth, differentiation, 
and homeostasis." 
 18(12): 1424-1426. 
Physiol Rev
Musil, L. S., E. C. Beyer, et al. (1990). "Expression of the gap junction protein 
connexin43 in embryonic chick lens: molecular cloning, ultrastructural 
localization, and post-translational phosphorylation." 
 90(1): 179-206. 
J Membr Biol
Musil, L. S., A. C. Le, et al. (2000). "Regulation of connexin degradation as a 
mechanism to increase gap junction assembly and function." 
 116(2): 163-
175. 
J Biol Chem
Paemeleire, K., P. E. Martin, et al. (2000). "Intercellular calcium waves in HeLa cells 
expressing GFP-labeled connexin 43, 32, or 26." 
 
275(33): 25207-25215. 
Mol Biol Cell
Paul, D. L., L. Ebihara, et al. (1991). "Connexin46, a novel lens gap junction protein, 
induces voltage-gated currents in nonjunctional plasma membrane of Xenopus 
oocytes." 
 11(5): 1815-1827. 
J Cell Biol
Qin, H., Q. Shao, et al. (2002). "Retroviral delivery of connexin genes to human breast 
tumor cells inhibits in vivo tumor growth by a mechanism that is independent of 
 115(4): 1077-1089. 
166 
 
significant gap junctional intercellular communication." J Biol Chem
Qin, H., Q. Shao, et al. (2003). "Lysosomal and proteasomal degradation play distinct 
roles in the life cycle of Cx43 in gap junctional intercellular communication-
deficient and -competent breast tumor cells." 
 277(32): 
29132-29138. 
J Biol Chem
Rong, P., X. Wang, et al. (2002). "Disruption of Gja8 (alpha8 connexin) in mice leads to 
microphthalmia associated with retardation of lens growth and lens fiber 
maturation." 
 278(32): 30005-30014. 
Development
Saez, J. C., V. M. Berthoud, et al. (2003). "Plasma membrane channels formed by 
connexins: their regulation and functions." 
 129(1): 167-174. 
Physiol Rev
Shao, Q., H. Wang, et al. (2005). "Down-regulation of Cx43 by retroviral delivery of 
small interfering RNA promotes an aggressive breast cancer cell phenotype." 
 83(4): 1359-1400. 
Cancer Res
Solan, J. L. and P. D. Lampe (2009). "Connexin43 phosphorylation: structural changes 
and biological effects." 
 65(7): 2705-2711. 
Biochem J
TenBroek, E. M., R. Johnson, et al. (1994). "Cell-to-cell communication in a 
differentiating ovine lens culture system." 
 419(2): 261-272. 
Invest Ophthalmol Vis Sci
Thomas, T., K. Jordan, et al. (2005). "Mechanisms of Cx43 and Cx26 transport to the 
plasma membrane and gap junction regeneration." 
 35(1): 215-
228. 
J Cell Sci 118(Pt 19): 4451-
4462. 
167 
 
Traub, O., J. Look, et al. (1989). "Comparative characterization of the 21-kD and 26-kD 
gap junction proteins in murine liver and cultured hepatocytes." J Cell Biol
Trosko, J. E. and R. J. Ruch (1998). "Cell-cell communication in carcinogenesis." 
 108(3): 
1039-1051. 
Front 
Biosci
VanSlyke, J. K., S. M. Deschenes, et al. (2000). "Intracellular transport, assembly, and 
degradation of wild-type and disease-linked mutant gap junction proteins." 
 3: d208-236. 
Mol 
Biol Cell
VanSlyke, J. K. and L. S. Musil (2002). "Dislocation and degradation from the ER are 
regulated by cytosolic stress." 
 11(6): 1933-1946. 
J Cell Biol
Wang, H. Z., S. W. Lee, et al. (2001). "Gap junction channel activity in cultured human 
bladder smooth muscle cell pairs: gating and unitary conductances." 
 157(3): 381-394. 
Urology
Wang, Q., R. Stump, et al. (2009). "MAPK/ERK1/2 and PI3-kinase signalling pathways 
are required for vitreous-induced lens fibre cell differentiation." 
 
57(6 Suppl 1): 111. 
Exp Eye Res
Wang, X., C. M. Garcia, et al. (2004). "Expression and regulation of alpha-, beta-, and 
gamma-crystallins in mammalian lens epithelial cells." 
 
88(2): 293-306. 
Invest Ophthalmol Vis Sci
White, T. W., R. Bruzzone, et al. (1992). "Mouse Cx50, a functional member of the 
connexin family of gap junction proteins, is the lens fiber protein MP70." 
 
45(10): 3608-3619. 
Mol Biol 
Cell
 
 3(7): 711-720. 
168 
 
 
 Chapter 4- Summary 
  
Breast cancer is the second most common form of cancer in women and one of 
the leading causes of cancer deaths in white, black, Asian/Pacific Islander, and 
American Indian/Alaska Native women. Therefore breast cancer tumorigenesis has 
been a subject of intense research for the last 10 years. In breast carcinogenesis 
among the most studied genes are those for hypoxia. Hypoxia induces cell-death of 
normal cells but breast tumors use hypoxia as an adaptation to grow and survive under 
nutrient deprived environment. Breast tumor is an adaptive hypoxic tissue but lens is a 
naturally hypoxic tissue in the animal body. Whether these two different tissues use the 
same survival strategies to escape from hypoxia-induced cell death has been largely 
unanswered. In the current studies, I have compared these two tissues to answer these 
questions. 
In lens Cx46 protein is abundantly expressed in the fiber cell region which is 
located at the very hypoxic center. Initially, I observed high levels of Cx46 protein in 
human breast cancer MCF-7 cells relative to normal breast epithelial cells (HMEC).The 
occurrence of Cx46 expression in the region of low oxygen led us to hypothesize that 
both lens and breast tumors use Cx46 protein as a means to survive under the adverse 
environment of hypoxia. The role of Cx46 was studied by the use of RNA interference 
(RNAi) technology. Knock-down of Cx46, by a selective siRNA, resulted in increased 
hypoxia-induced cell death of both human lens epithelial cells (HLEC) and breast 
cancer MCF-7 cells probably by the mechanisms independent of  Cx46 gap junction 
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activity. Hypoxia-specific role of Cx46 was also observed in hypoxia-sensitive connexin 
deficient neuronal N2A cells where exogenous expression of Cx46 rendered the cell 
hypoxia-resistant. The function of Cx46 in human breast tumor formation was further 
investigated, in vivo, in human tumor xenograft-bearing nude mice. The tumor of human 
origin in nude mice was generated by injecting human MCF-7 cancer cells into the 
inguinal region of mammary fat pads. Direct injection of the anti-Cx46 siRNA into the 
tumor inhibited tumors volume significantly, suggesting a possible role of Cx46 in breast 
tumor growth. 
Among the members of connexin family of proteins, Cx43 is most extensively 
studied and regarded as a tumor suppressor. Several studies have shown that the 
expression of Cx43 is downregulated in breast tumors as compared to normal breast 
tissues. Therefore, Cx43 is reciprocally expressed when compared with Cx46 in breast 
tumors. This reciprocal relationship of Cx43 and Cx46 expression is also seen in lens 
during differentiation. In lens epithelial cells Cx43 is highly expressed whereas Cx46 
has low expression. However in the lens fiber cells, which are differentiated from the 
epithelial cells, Cx43 is downregulated and Cx46 is abundantly expressed. In last part of 
my dissertation work, I looked into how Cx46 is associated with Cx43 degradation using 
rabbit lens epithelial cells. Overexpression of Cx46 caused a decrease in only protein 
levels of Cx43 while mRNA levels were not reduced. This Cx46-induced degradation of 
Cx43 was independent of its gap junction activity and completely counteracted by 
inhibitors of proteasome. The overexpression of Cx46 also increased the ubiquitin 
conjugation of Cx43, thereby suggesting that degradation is mediated by the 
proteasome. The C terminal deletion mutant of Cx46, when overexpressed, did not 
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reduce the Cx43 protein levels indicating the-C-terminal region, which has least 
sequence similarity among various domains of different connexins, is the part of Cx46 
that is required to mediate degradation of Cx43. 
 
In summary, I have established the novel functions of a protein Cx46, as survival 
factor in hypoxic cell death and as the regulator of turnover of another connexin, Cx43. 
These findings will help gain a better knowledge of processes such as breast 
tumorigenesis and lens differentiation. 
 
 
 
 
 
 
 
